| Category | Name | IntersectionWithQuery | PValue | GenesInTerm | GenesInQuery | GenesInTermInQuery | ID |
|---|---|---|---|---|---|---|---|
| GeneOntologyMolecularFunction | nucleosomal DNA binding | 2.04e-06 | 67 | 62 | 5 | GO:0031492 | |
| GeneOntologyMolecularFunction | chromatin binding | HMGN5 SAFB PSIP1 RNF20 CBX1 MACROH2A2 MACROH2A1 CHD3 CHD4 PHF10 HMGN3 HDGFL3 | 2.38e-06 | 739 | 62 | 12 | GO:0003682 |
| GeneOntologyMolecularFunction | P-type calcium transporter activity | 4.62e-06 | 11 | 62 | 3 | GO:0005388 | |
| GeneOntologyMolecularFunction | ATP hydrolysis activity | 8.29e-06 | 441 | 62 | 9 | GO:0016887 | |
| GeneOntologyMolecularFunction | nucleosome binding | 1.33e-05 | 98 | 62 | 5 | GO:0031491 | |
| GeneOntologyMolecularFunction | ATP-dependent activity | 1.79e-05 | 614 | 62 | 10 | GO:0140657 | |
| GeneOntologyMolecularFunction | helicase activity | 1.31e-04 | 158 | 62 | 5 | GO:0004386 | |
| GeneOntologyMolecularFunction | chromatin DNA binding | 1.70e-04 | 167 | 62 | 5 | GO:0031490 | |
| GeneOntologyMolecularFunction | P-type transmembrane transporter activity | 1.89e-04 | 36 | 62 | 3 | GO:0140358 | |
| GeneOntologyMolecularFunction | P-type ion transporter activity | 1.89e-04 | 36 | 62 | 3 | GO:0015662 | |
| GeneOntologyMolecularFunction | ATP-dependent chromatin remodeler activity | 2.05e-04 | 37 | 62 | 3 | GO:0140658 | |
| GeneOntologyMolecularFunction | ribonucleoside triphosphate phosphatase activity | 6.12e-04 | 775 | 62 | 9 | GO:0017111 | |
| GeneOntologyMolecularFunction | histone ubiquitin ligase activity | 6.14e-04 | 12 | 62 | 2 | GO:0140852 | |
| GeneOntologyMolecularFunction | ATPase-coupled monoatomic cation transmembrane transporter activity | 9.46e-04 | 62 | 62 | 3 | GO:0019829 | |
| GeneOntologyMolecularFunction | pyrophosphatase activity | 1.07e-03 | 839 | 62 | 9 | GO:0016462 | |
| GeneOntologyMolecularFunction | hydrolase activity, acting on acid anhydrides | 1.08e-03 | 840 | 62 | 9 | GO:0016817 | |
| GeneOntologyMolecularFunction | hydrolase activity, acting on acid anhydrides, in phosphorus-containing anhydrides | 1.08e-03 | 840 | 62 | 9 | GO:0016818 | |
| GeneOntologyMolecularFunction | calcium ion transmembrane transporter activity | 1.25e-03 | 151 | 62 | 4 | GO:0015085 | |
| GeneOntologyMolecularFunction | histone binding | 1.38e-03 | 265 | 62 | 5 | GO:0042393 | |
| GeneOntologyMolecularFunction | phosphatidylinositol-4,5-bisphosphate binding | 3.22e-03 | 95 | 62 | 3 | GO:0005546 | |
| GeneOntologyBiologicalProcess | chromatin organization | HMGN5 TTF2 ACTR8 SAFB PSIP1 ANP32B CTR9 CFDP1 RNF20 CBX1 MACROH2A2 MACROH2A1 CHD3 CHD4 HUWE1 PHF10 HMGN3 HDGFL3 | 1.05e-10 | 896 | 63 | 18 | GO:0006325 |
| GeneOntologyBiologicalProcess | protein-DNA complex organization | HMGN5 TTF2 ACTR8 SAFB PSIP1 ANP32B CTR9 CFDP1 RNF20 CBX1 MACROH2A2 MACROH2A1 CHD3 CHD4 HUWE1 PHF10 HMGN3 HDGFL3 | 6.06e-10 | 999 | 63 | 18 | GO:0071824 |
| GeneOntologyBiologicalProcess | chromatin remodeling | TTF2 ACTR8 PSIP1 ANP32B CTR9 CFDP1 RNF20 CBX1 MACROH2A2 MACROH2A1 CHD3 CHD4 HUWE1 PHF10 HDGFL3 | 4.57e-09 | 741 | 63 | 15 | GO:0006338 |
| GeneOntologyBiologicalProcess | calcium ion export | 5.49e-05 | 4 | 63 | 2 | GO:1901660 | |
| GeneOntologyBiologicalProcess | negative regulation of transcription of nucleolar large rRNA by RNA polymerase I | 5.49e-05 | 4 | 63 | 2 | GO:1901837 | |
| GeneOntologyBiologicalProcess | regulation of cardiac conduction | 9.38e-05 | 29 | 63 | 3 | GO:1903779 | |
| GeneOntologyCellularComponent | chromatin | HMGN5 ACTR8 BBX PSIP1 CTR9 CFDP1 RNF20 ANKRD11 CBX1 MACROH2A2 MACROH2A1 CHD3 CHD4 PHF10 HMGN3 AKAP8L | 6.95e-06 | 1480 | 64 | 16 | GO:0000785 |
| GeneOntologyCellularComponent | SWI/SNF superfamily-type complex | 1.13e-05 | 96 | 64 | 5 | GO:0070603 | |
| GeneOntologyCellularComponent | ATPase complex | 4.72e-05 | 129 | 64 | 5 | GO:1904949 | |
| GeneOntologyCellularComponent | postsynaptic cytoskeleton | 6.77e-05 | 26 | 64 | 3 | GO:0099571 | |
| GeneOntologyCellularComponent | Barr body | 2.55e-04 | 8 | 64 | 2 | GO:0001740 | |
| GeneOntologyCellularComponent | photoreceptor outer segment | 3.74e-04 | 111 | 64 | 4 | GO:0001750 | |
| GeneOntologyCellularComponent | spliceosomal complex | 5.12e-04 | 215 | 64 | 5 | GO:0005681 | |
| GeneOntologyCellularComponent | X chromosome | 7.04e-04 | 13 | 64 | 2 | GO:0000805 | |
| GeneOntologyCellularComponent | neurofilament | 8.20e-04 | 14 | 64 | 2 | GO:0005883 | |
| GeneOntologyCellularComponent | photoreceptor cell cilium | 8.73e-04 | 139 | 64 | 4 | GO:0097733 | |
| GeneOntologyCellularComponent | CHD-type complex | 1.22e-03 | 17 | 64 | 2 | GO:0090545 | |
| GeneOntologyCellularComponent | NuRD complex | 1.22e-03 | 17 | 64 | 2 | GO:0016581 | |
| GeneOntologyCellularComponent | 9+0 non-motile cilium | 1.25e-03 | 153 | 64 | 4 | GO:0097731 | |
| GeneOntologyCellularComponent | myofibril | 1.49e-03 | 273 | 64 | 5 | GO:0030016 | |
| GeneOntologyCellularComponent | presynaptic membrane | 1.59e-03 | 277 | 64 | 5 | GO:0042734 | |
| GeneOntologyCellularComponent | chromosomal region | 1.80e-03 | 421 | 64 | 6 | GO:0098687 | |
| GeneOntologyCellularComponent | contractile muscle fiber | 1.94e-03 | 290 | 64 | 5 | GO:0043292 | |
| GeneOntologyCellularComponent | costamere | 2.05e-03 | 22 | 64 | 2 | GO:0043034 | |
| GeneOntologyCellularComponent | chromosome, telomeric region | 2.08e-03 | 176 | 64 | 4 | GO:0000781 | |
| GeneOntologyCellularComponent | histone deacetylase complex | 2.26e-03 | 85 | 64 | 3 | GO:0000118 | |
| GeneOntologyCellularComponent | nuclear protein-containing complex | DHX16 TTF2 ACTR8 PTBP2 CTR9 CFDP1 CHD3 CHD4 CCDC12 PHF10 AQR | 2.86e-03 | 1377 | 64 | 11 | GO:0140513 |
| GeneOntologyCellularComponent | non-motile cilium | 3.07e-03 | 196 | 64 | 4 | GO:0097730 | |
| GeneOntologyCellularComponent | U2-type spliceosomal complex | 3.29e-03 | 97 | 64 | 3 | GO:0005684 | |
| GeneOntologyCellularComponent | INO80-type complex | 3.31e-03 | 28 | 64 | 2 | GO:0097346 | |
| GeneOntologyCellularComponent | pronucleus | 3.31e-03 | 28 | 64 | 2 | GO:0045120 | |
| GeneOntologyCellularComponent | heterochromatin | 3.68e-03 | 101 | 64 | 3 | GO:0000792 | |
| GeneOntologyCellularComponent | pericentric heterochromatin | 4.31e-03 | 32 | 64 | 2 | GO:0005721 | |
| Domain | ATP_Ca_trans_C | 1.46e-07 | 4 | 63 | 3 | IPR022141 | |
| Domain | ATP_Ca_trans_C | 1.46e-07 | 4 | 63 | 3 | PF12424 | |
| Domain | P-type_ATPase_IIB | 1.46e-07 | 4 | 63 | 3 | IPR006408 | |
| Domain | DNA/RNA_helicase_DEAH_CS | 5.69e-06 | 35 | 63 | 4 | IPR002464 | |
| Domain | DEAH_ATP_HELICASE | 7.96e-06 | 38 | 63 | 4 | PS00690 | |
| Domain | Core_histone_macro-H2A | 1.12e-05 | 2 | 63 | 2 | IPR021171 | |
| Domain | ATP2B1/4 | 1.12e-05 | 2 | 63 | 2 | IPR030319 | |
| Domain | - | 1.99e-05 | 16 | 63 | 3 | 1.20.1110.10 | |
| Domain | ATPase_P-typ_TM_dom | 1.99e-05 | 16 | 63 | 3 | IPR023298 | |
| Domain | ATPase_P-typ_cation-transptr_C | 2.40e-05 | 17 | 63 | 3 | IPR006068 | |
| Domain | Cation_ATPase_C | 2.40e-05 | 17 | 63 | 3 | PF00689 | |
| Domain | Cation_ATPase_N | 2.88e-05 | 18 | 63 | 3 | PF00690 | |
| Domain | Cation_ATPase_N | 2.88e-05 | 18 | 63 | 3 | SM00831 | |
| Domain | CHDCT2 | 3.35e-05 | 3 | 63 | 2 | PF08074 | |
| Domain | CHDNT | 3.35e-05 | 3 | 63 | 2 | PF08073 | |
| Domain | DUF1086 | 3.35e-05 | 3 | 63 | 2 | IPR009462 | |
| Domain | DUF1087 | 3.35e-05 | 3 | 63 | 2 | IPR009463 | |
| Domain | CHD_N | 3.35e-05 | 3 | 63 | 2 | IPR012958 | |
| Domain | CHD_C2 | 3.35e-05 | 3 | 63 | 2 | IPR012957 | |
| Domain | DUF1087 | 3.35e-05 | 3 | 63 | 2 | PF06465 | |
| Domain | DUF1086 | 3.35e-05 | 3 | 63 | 2 | PF06461 | |
| Domain | DUF1087 | 3.35e-05 | 3 | 63 | 2 | SM01147 | |
| Domain | DUF1086 | 3.35e-05 | 3 | 63 | 2 | SM01146 | |
| Domain | ATPase_P-typ_cation-transptr_N | 3.41e-05 | 19 | 63 | 3 | IPR004014 | |
| Domain | Chromo_domain | 7.04e-05 | 24 | 63 | 3 | IPR023780 | |
| Domain | Chromo | 9.00e-05 | 26 | 63 | 3 | PF00385 | |
| Domain | HMG14_17 | 1.11e-04 | 5 | 63 | 2 | PS00355 | |
| Domain | HMG17 | 1.11e-04 | 5 | 63 | 2 | SM00527 | |
| Domain | HMG14_17 | 1.11e-04 | 5 | 63 | 2 | PF01101 | |
| Domain | HMGN_fam | 1.11e-04 | 5 | 63 | 2 | IPR000079 | |
| Domain | CHROMO_1 | 1.13e-04 | 28 | 63 | 3 | PS00598 | |
| Domain | CHROMO_2 | 1.13e-04 | 28 | 63 | 3 | PS50013 | |
| Domain | SNF2_N | 1.69e-04 | 32 | 63 | 3 | IPR000330 | |
| Domain | Chromodomain-like | 1.69e-04 | 32 | 63 | 3 | IPR016197 | |
| Domain | SNF2_N | 1.69e-04 | 32 | 63 | 3 | PF00176 | |
| Domain | Chromo/shadow_dom | 1.86e-04 | 33 | 63 | 3 | IPR000953 | |
| Domain | CHROMO | 1.86e-04 | 33 | 63 | 3 | SM00298 | |
| Domain | ATPase_P-typ_cyto_domN | 2.22e-04 | 35 | 63 | 3 | IPR023299 | |
| Domain | P_typ_ATPase | 2.41e-04 | 36 | 63 | 3 | IPR001757 | |
| Domain | ATPase_P-typ_P_site | 2.41e-04 | 36 | 63 | 3 | IPR018303 | |
| Domain | ATPASE_E1_E2 | 2.41e-04 | 36 | 63 | 3 | PS00154 | |
| Domain | ATPase_P-typ_transduc_dom_A | 2.62e-04 | 37 | 63 | 3 | IPR008250 | |
| Domain | E1-E2_ATPase | 2.62e-04 | 37 | 63 | 3 | PF00122 | |
| Domain | A1pp | 3.97e-04 | 9 | 63 | 2 | SM00506 | |
| Domain | Macro | 3.97e-04 | 9 | 63 | 2 | PF01661 | |
| Domain | Helicase_C | 4.68e-04 | 107 | 63 | 4 | PF00271 | |
| Domain | HELICc | 4.68e-04 | 107 | 63 | 4 | SM00490 | |
| Domain | Helicase_C | 4.84e-04 | 108 | 63 | 4 | IPR001650 | |
| Domain | MACRO | 4.95e-04 | 10 | 63 | 2 | PS51154 | |
| Domain | Macro_dom | 4.95e-04 | 10 | 63 | 2 | IPR002589 | |
| Domain | HELICASE_CTER | 5.02e-04 | 109 | 63 | 4 | PS51194 | |
| Domain | HELICASE_ATP_BIND_1 | 5.02e-04 | 109 | 63 | 4 | PS51192 | |
| Domain | DEXDc | 5.02e-04 | 109 | 63 | 4 | SM00487 | |
| Domain | Helicase_ATP-bd | 5.19e-04 | 110 | 63 | 4 | IPR014001 | |
| Domain | HMG_box_dom | 1.38e-03 | 65 | 63 | 3 | IPR009071 | |
| Domain | Histone_H2A_C | 1.47e-03 | 17 | 63 | 2 | IPR032454 | |
| Domain | Histone_H2A_C | 1.47e-03 | 17 | 63 | 2 | PF16211 | |
| Domain | Chromodomain_CS | 1.65e-03 | 18 | 63 | 2 | IPR023779 | |
| Domain | PWWP | 2.05e-03 | 20 | 63 | 2 | SM00293 | |
| Domain | PHD | 2.08e-03 | 75 | 63 | 3 | PF00628 | |
| Domain | HAD-like_dom | 2.41e-03 | 79 | 63 | 3 | IPR023214 | |
| Domain | Znf_PHD-finger | 2.41e-03 | 79 | 63 | 3 | IPR019787 | |
| Domain | PWWP | 2.71e-03 | 23 | 63 | 2 | PF00855 | |
| Domain | H2A | 2.71e-03 | 23 | 63 | 2 | SM00414 | |
| Domain | PWWP_dom | 2.71e-03 | 23 | 63 | 2 | IPR000313 | |
| Domain | Histone_H2A | 2.71e-03 | 23 | 63 | 2 | IPR002119 | |
| Domain | PWWP | 2.95e-03 | 24 | 63 | 2 | PS50812 | |
| Pathway | REACTOME_REDUCTION_OF_CYTOSOLIC_CA_LEVELS | 6.55e-06 | 12 | 45 | 3 | M27326 | |
| Pathway | REACTOME_REDUCTION_OF_CYTOSOLIC_CA_LEVELS | 1.08e-05 | 14 | 45 | 3 | MM15052 | |
| Pathway | WP_COVID19_STRUCTURAL_COVERAGE_MAP | 7.51e-05 | 26 | 45 | 3 | M48318 | |
| Pathway | REACTOME_PLATELET_CALCIUM_HOMEOSTASIS | 8.43e-05 | 27 | 45 | 3 | MM15053 | |
| Pathway | REACTOME_PLATELET_CALCIUM_HOMEOSTASIS | 9.42e-05 | 28 | 45 | 3 | M924 | |
| Pathway | WP_VITAMIN_DSENSITIVE_CALCIUM_SIGNALING_IN_DEPRESSION | 2.02e-04 | 36 | 45 | 3 | M39831 | |
| Pathway | WP_EFFECT_OF_PROGERIN_ON_GENES_INVOLVED_IN_PROGERIA | 2.19e-04 | 37 | 45 | 3 | M39756 | |
| Pathway | KEGG_CALCIUM_SIGNALING_PATHWAY | 2.46e-04 | 178 | 45 | 5 | M2890 | |
| Pathway | REACTOME_ION_HOMEOSTASIS | 6.73e-04 | 54 | 45 | 3 | MM15202 | |
| Pathway | REACTOME_ION_HOMEOSTASIS | 6.73e-04 | 54 | 45 | 3 | M27460 | |
| Pathway | REACTOME_ION_TRANSPORT_BY_P_TYPE_ATPASES | 7.10e-04 | 55 | 45 | 3 | M971 | |
| Pathway | REACTOME_ION_TRANSPORT_BY_P_TYPE_ATPASES | 7.88e-04 | 57 | 45 | 3 | MM15643 | |
| Pathway | REACTOME_PLATELET_HOMEOSTASIS | 1.82e-03 | 76 | 45 | 3 | MM15051 | |
| Pathway | REACTOME_MUSCLE_CONTRACTION | 1.86e-03 | 165 | 45 | 4 | MM15026 | |
| Pubmed | Gain of Additional BIRC3 Protein Functions through 3'-UTR-Mediated Protein Complex Formation. | DHX16 SRRT SAFB ABCF1 PSIP1 AIMP1 DYNC2H1 ANP32B CTR9 RNF20 ZFR MACROH2A1 CHD4 HUWE1 CMYA5 LYAR ATP2B1 ATP2B3 MARCKS AQR | 5.47e-13 | 1425 | 64 | 20 | 30948266 |
| Pubmed | Large-scale characterization of HeLa cell nuclear phosphoproteins. | DHX16 SRRT SAFB ABCF1 PSIP1 CTR9 ITSN1 SVIL RNF20 CHD3 CHD4 HUWE1 PHF10 REXO1 AKAP8L | 8.26e-12 | 774 | 64 | 15 | 15302935 |
| Pubmed | Proteomic profiling of VCP substrates links VCP to K6-linked ubiquitylation and c-Myc function. | DHX16 SRRT TTF2 SAFB ABCF1 NAA15 CTR9 RNF20 CBX1 ZFR MACROH2A2 MACROH2A1 CHD4 HUWE1 LYAR ATP2B1 AKAP8L AQR | 2.45e-11 | 1353 | 64 | 18 | 29467282 |
| Pubmed | DHX16 SRRT SAFB PSIP1 ANP32B CTR9 CFDP1 RNF20 ZFR MACROH2A1 CHD3 CHD4 CCDC12 LYAR HMGN3 AQR | 3.19e-11 | 1014 | 64 | 16 | 32416067 | |
| Pubmed | MECP2 directly interacts with RNA polymerase II to modulate transcription in human neurons. | DHX16 NEFM SRRT SAFB ABCF1 BBX PSIP1 PTBP2 CBX1 MACROH2A2 MACROH2A1 CHD4 LYAR AKAP8L MARCKS AQR | 8.30e-11 | 1082 | 64 | 16 | 38697112 |
| Pubmed | DHX16 SRRT SAFB ABCF1 NAA15 PSIP1 AIMP1 PTBP2 CTR9 CFDP1 ZFR CHD3 LYAR | 1.75e-10 | 653 | 64 | 13 | 33742100 | |
| Pubmed | Identifying biological pathways that underlie primordial short stature using network analysis. | DHX16 SRRT SAFB ABCF1 PSIP1 SVIL CBX1 ZFR MACROH2A2 MACROH2A1 CHD3 CHD4 HUWE1 ATP2B1 AQR | 4.06e-10 | 1024 | 64 | 15 | 24711643 |
| Pubmed | CYLC2 NEFM SAFB BBX PSIP1 PTBP2 CTR9 ITSN1 MAP7D2 ZFR MACROH2A1 CHD3 CHD4 ATP2B1 HMGN3 ATP2B3 AKAP8L | 6.26e-10 | 1442 | 64 | 17 | 35575683 | |
| Pubmed | SRRT SAFB PSIP1 AIMP1 CTR9 ZFR MACROH2A2 MACROH2A1 CHD4 CCDC12 LYAR AKAP8L AQR | 6.90e-10 | 731 | 64 | 13 | 29298432 | |
| Pubmed | H4K20me0 recognition by BRCA1-BARD1 directs homologous recombination to sister chromatids. | HMGN5 SRRT TTF2 ACTR8 SAFB BBX PSIP1 CTR9 RNF20 ANKRD11 ZFR CHD3 CHD4 CCDC12 LYAR HMGN3 | 1.12e-09 | 1294 | 64 | 16 | 30804502 |
| Pubmed | The functional interactome landscape of the human histone deacetylase family. | 3.08e-09 | 289 | 64 | 9 | 23752268 | |
| Pubmed | Interactome Rewiring Following Pharmacological Targeting of BET Bromodomains. | ACTR8 ABCF1 BBX PSIP1 CBX1 MACROH2A2 MACROH2A1 CHD3 CHD4 HMGN3 HDGFL3 | 3.53e-09 | 533 | 64 | 11 | 30554943 |
| Pubmed | Two-Dimensional Fractionation Method for Proteome-Wide Cross-Linking Mass Spectrometry Analysis. | NEFM TTF2 NAA15 PSIP1 AIMP1 PTBP2 RNF20 ZFR CHD3 CHD4 ATP2B1 ATP2B4 DENR | 4.04e-09 | 847 | 64 | 13 | 35235311 |
| Pubmed | Proteomic analyses reveal distinct chromatin-associated and soluble transcription factor complexes. | DHX16 NEFM TTF2 BBX PSIP1 CFDP1 ZFR MACROH2A2 MACROH2A1 CHD4 HUWE1 ATP2B1 ATP2B3 | 4.65e-09 | 857 | 64 | 13 | 25609649 |
| Pubmed | ZFR coordinates crosstalk between RNA decay and transcription in innate immunity. | 5.94e-09 | 3 | 64 | 3 | 29559679 | |
| Pubmed | Targeting USP10 induces degradation of oncogenic ANLN in esophageal squamous cell carcinoma. | DHX16 SRRT SAFB ABCF1 NAA15 PSIP1 AIMP1 SVIL CBX1 ZFR MACROH2A1 LYAR MARCKS AQR MICU1 | 6.53e-09 | 1257 | 64 | 15 | 36526897 |
| Pubmed | ABCF1 NAA15 PSIP1 DYNC2H1 ANP32B CTR9 ITSN1 PBDC1 ANKRD11 MAP7D2 MACROH2A1 ATP2B1 ATP2B4 MARCKS AQR MICU1 | 8.06e-09 | 1487 | 64 | 16 | 33957083 | |
| Pubmed | Identification of SUMO Binding Proteins Enriched after Covalent Photo-Cross-Linking. | 1.03e-08 | 332 | 64 | 9 | 32786267 | |
| Pubmed | The E3 ubiquitin ligase HECTD1 contributes to cell proliferation through an effect on mitosis. | SRRT ABCF1 PSIP1 AIMP1 ZFR MACROH2A2 MACROH2A1 CHD3 CHD4 LYAR AKAP8L AQR | 1.24e-08 | 759 | 64 | 12 | 35915203 |
| Pubmed | CHD3 and CHD4 form distinct NuRD complexes with different yet overlapping functionality. | 1.30e-08 | 605 | 64 | 11 | 28977666 | |
| Pubmed | The in vivo Interaction Landscape of Histones H3.1 and H3.3. | DHX16 HMGN5 BBX PSIP1 PTBP2 CFDP1 CBX1 CHD3 CHD4 LYAR HDGFL3 | 1.37e-08 | 608 | 64 | 11 | 36089195 |
| Pubmed | The Nse5/6-like SIMC1-SLF2 complex localizes SMC5/6 to viral replication centers. | SRRT SAFB BBX PSIP1 PTBP2 ANKRD11 CBX1 ZFR MACROH2A1 CHD3 CHD4 LYAR HDGFL3 | 1.65e-08 | 954 | 64 | 13 | 36373674 |
| Pubmed | A bead-based approach for large-scale identification of in vitro kinase substrates. | 2.17e-08 | 163 | 64 | 7 | 22113938 | |
| Pubmed | Structural organization, ion transport, and energy transduction of P-type ATPases. | 2.37e-08 | 4 | 64 | 3 | 8634322 | |
| Pubmed | Cell-specific expression of plasma membrane calcium ATPase isoforms in retinal neurons. | 2.37e-08 | 4 | 64 | 3 | 12209837 | |
| Pubmed | Quantitative analysis of alternative splicing options of human plasma membrane calcium pump genes. | 2.37e-08 | 4 | 64 | 3 | 7989379 | |
| Pubmed | Role of alternative splicing in generating isoform diversity among plasma membrane calcium pumps. | 2.37e-08 | 4 | 64 | 3 | 11152753 | |
| Pubmed | 2.37e-08 | 4 | 64 | 3 | 12784250 | ||
| Pubmed | 2.37e-08 | 4 | 64 | 3 | 15101689 | ||
| Pubmed | PMCA1 depletion in mouse eggs amplifies calcium signaling and impacts offspring growth†. | 2.37e-08 | 4 | 64 | 3 | 36130203 | |
| Pubmed | 2.37e-08 | 4 | 64 | 3 | 23413890 | ||
| Pubmed | Developmental expression of the four plasma membrane calcium ATPase (Pmca) genes in the mouse. | 2.37e-08 | 4 | 64 | 3 | 10434059 | |
| Pubmed | Quantitative analysis of alternative splicing options of human plasma membrane calcium pump genes. | 2.37e-08 | 4 | 64 | 3 | 8245032 | |
| Pubmed | 2.37e-08 | 4 | 64 | 3 | 10577388 | ||
| Pubmed | 3.80e-08 | 103 | 64 | 6 | 32744500 | ||
| Pubmed | 5.93e-08 | 5 | 64 | 3 | 17938178 | ||
| Pubmed | 9.43e-08 | 202 | 64 | 7 | 24639526 | ||
| Pubmed | BAP1 regulation of the key adaptor protein NCoR1 is critical for γ-globin gene repression. | DHX16 HMGN5 SAFB ABCF1 AIMP1 CTR9 CBX1 MACROH2A1 CHD4 HUWE1 CCDC12 LYAR AKAP8L AQR | 9.56e-08 | 1318 | 64 | 14 | 30463901 |
| Pubmed | ABCF1 AIMP1 PBDC1 CBX1 PCNX1 ZFR MACROH2A1 CHD3 CHD4 HUWE1 LYAR PHF10 AKAP8L DENR | 1.12e-07 | 1335 | 64 | 14 | 29229926 | |
| Pubmed | Cardiac excitation-contraction coupling in the absence of Na(+) - Ca2+ exchange. | 1.18e-07 | 6 | 64 | 3 | 12767889 | |
| Pubmed | N-Terminal Acetyltransferase Naa40p Whereabouts Put into N-Terminal Proteoform Perspective. | TTF2 SAFB ABCF1 NAA15 PSIP1 CFDP1 CBX1 ZFR MACROH2A1 CHD3 CHD4 MARCKS | 1.19e-07 | 934 | 64 | 12 | 33916271 |
| Pubmed | DHX16 SRRT PSIP1 AIMP1 SVIL MACROH2A1 CHD3 CHD4 LYAR PHF10 ATP2B4 AKAP8L DENR MARCKS | 1.55e-07 | 1371 | 64 | 14 | 36244648 | |
| Pubmed | ZBTB2 protein is a new partner of the Nucleosome Remodeling and Deacetylase (NuRD) complex. | 1.68e-07 | 330 | 64 | 8 | 33301849 | |
| Pubmed | The mRNA-bound proteome and its global occupancy profile on protein-coding transcripts. | 2.38e-07 | 807 | 64 | 11 | 22681889 | |
| Pubmed | 3.31e-07 | 8 | 64 | 3 | 10951186 | ||
| Pubmed | 3.39e-07 | 244 | 64 | 7 | 29884807 | ||
| Pubmed | 3.41e-07 | 660 | 64 | 10 | 32780723 | ||
| Pubmed | 4.10e-07 | 251 | 64 | 7 | 31076518 | ||
| Pubmed | 4.10e-07 | 251 | 64 | 7 | 28077445 | ||
| Pubmed | WDR76 Co-Localizes with Heterochromatin Related Proteins and Rapidly Responds to DNA Damage. | 6.43e-07 | 394 | 64 | 8 | 27248496 | |
| Pubmed | Maternal Transient Receptor Potential Vanilloid 6 (Trpv6) Is Involved In Offspring Bone Development. | 7.34e-07 | 38 | 64 | 4 | 30786075 | |
| Pubmed | HMGN5 SRRT ITSN1 CBX1 ZFR HUWE1 CCDC12 LYAR HMGN3 AKAP8L MARCKS | 8.29e-07 | 916 | 64 | 11 | 32203420 | |
| Pubmed | 9.37e-07 | 177 | 64 | 6 | 26206133 | ||
| Pubmed | SRRT TTF2 ABCF1 CTR9 ZFR HUWE1 LYAR ATP2B1 AKAP8L MARCKS AQR | 1.46e-06 | 971 | 64 | 11 | 33306668 | |
| Pubmed | Reciprocal interaction between SIRT6 and APC/C regulates genomic stability. | 1.47e-06 | 440 | 64 | 8 | 34244565 | |
| Pubmed | 1.49e-06 | 441 | 64 | 8 | 31239290 | ||
| Pubmed | Assembly of the U5 snRNP component PRPF8 is controlled by the HSP90/R2TP chaperones. | SRRT ABCF1 NAA15 PSIP1 AIMP1 ANP32B CTR9 RNF20 CHD4 HUWE1 LYAR MARCKS AQR | 1.50e-06 | 1415 | 64 | 13 | 28515276 |
| Pubmed | NEFM SRRT SAFB AIMP1 PBDC1 CBX1 MACROH2A2 MACROH2A1 CHD4 HUWE1 | 1.65e-06 | 786 | 64 | 10 | 29128334 | |
| Pubmed | MYC multimers shield stalled replication forks from RNA polymerase. | SRRT SAFB ANP32B CTR9 RNF20 ZFR MACROH2A1 CHD4 HUWE1 LYAR AKAP8L | 1.75e-06 | 989 | 64 | 11 | 36424410 |
| Pubmed | Hdac4 Interactions in Huntington's Disease Viewed Through the Prism of Multiomics. | 2.59e-06 | 475 | 64 | 8 | 31040226 | |
| Pubmed | 2.64e-06 | 332 | 64 | 7 | 37433992 | ||
| Pubmed | 2.64e-06 | 332 | 64 | 7 | 25693804 | ||
| Pubmed | 2.90e-06 | 650 | 64 | 9 | 38777146 | ||
| Pubmed | 2.97e-06 | 652 | 64 | 9 | 31180492 | ||
| Pubmed | 3.21e-06 | 847 | 64 | 10 | 35850772 | ||
| Pubmed | Molecular analysis of a major antigenic region of the 240-kD protein of Mi-2 autoantigen. | 3.33e-06 | 2 | 64 | 2 | 7560064 | |
| Pubmed | 3.33e-06 | 2 | 64 | 2 | 1531651 | ||
| Pubmed | Macro histone variants are critical for the differentiation of human pluripotent cells. | 3.33e-06 | 2 | 64 | 2 | 23595991 | |
| Pubmed | 3.33e-06 | 2 | 64 | 2 | 15178683 | ||
| Pubmed | MACROH2A2, a new member of the MARCOH2A core histone family. | 3.33e-06 | 2 | 64 | 2 | 11262398 | |
| Pubmed | 3.33e-06 | 2 | 64 | 2 | 18657858 | ||
| Pubmed | MacroH2A histone variants act as a barrier upon reprogramming towards pluripotency. | 3.33e-06 | 2 | 64 | 2 | 23463008 | |
| Pubmed | 3.33e-06 | 2 | 64 | 2 | 16291816 | ||
| Pubmed | Regulation of plasma membrane Ca2+-ATPase by small GTPases and phosphoinositides in human platelets. | 3.33e-06 | 2 | 64 | 2 | 10748016 | |
| Pubmed | 3.33e-06 | 2 | 64 | 2 | 26116539 | ||
| Pubmed | The influence of membrane lipid structure on plasma membrane Ca2+ -ATPase activity. | 3.33e-06 | 2 | 64 | 2 | 16412504 | |
| Pubmed | 3.33e-06 | 2 | 64 | 2 | 37605008 | ||
| Pubmed | Histone macroH2A isoforms predict the risk of lung cancer recurrence. | 3.33e-06 | 2 | 64 | 2 | 19648962 | |
| Pubmed | 3.33e-06 | 2 | 64 | 2 | 16956963 | ||
| Pubmed | Mouse Chd4-NURD is required for neonatal spermatogonia survival and normal gonad development. | 3.33e-06 | 2 | 64 | 2 | 35568926 | |
| Pubmed | 3.33e-06 | 2 | 64 | 2 | 1674727 | ||
| Pubmed | 3.33e-06 | 2 | 64 | 2 | 7575689 | ||
| Pubmed | 3.33e-06 | 2 | 64 | 2 | 23266958 | ||
| Pubmed | Two forms of the major antigenic protein of the dermatomyositis-specific Mi-2 autoantigen. | 3.33e-06 | 2 | 64 | 2 | 8843877 | |
| Pubmed | 3.33e-06 | 2 | 64 | 2 | 21738686 | ||
| Pubmed | Jade-1S phosphorylation induced by CK1α contributes to cell cycle progression. | 3.56e-06 | 56 | 64 | 4 | 26919559 | |
| Pubmed | The functional interactome of PYHIN immune regulators reveals IFIX is a sensor of viral DNA. | 3.67e-06 | 349 | 64 | 7 | 25665578 | |
| Pubmed | 4.50e-06 | 360 | 64 | 7 | 33111431 | ||
| Pubmed | 4.71e-06 | 60 | 64 | 4 | 19075228 | ||
| Pubmed | 4.75e-06 | 18 | 64 | 3 | 29743367 | ||
| Pubmed | 6.13e-06 | 713 | 64 | 9 | 29802200 | ||
| Pubmed | Anticancer sulfonamides target splicing by inducing RBM39 degradation via recruitment to DCAF15. | 6.19e-06 | 714 | 64 | 9 | 28302793 | |
| Pubmed | 6.27e-06 | 246 | 64 | 6 | 15345747 | ||
| Pubmed | SAFB ABCF1 NAA15 AIMP1 MAP7D2 MACROH2A1 HUWE1 AQP4 AKAP8L MARCKS MICU1 | 6.72e-06 | 1139 | 64 | 11 | 36417873 | |
| Pubmed | Tumor suppressor BAP1 nuclear import is governed by transportin-1. | NEFM ABCF1 NAA15 AIMP1 ANP32B SVIL CHD4 HUWE1 LYAR AKAP8L MARCKS | 7.29e-06 | 1149 | 64 | 11 | 35446349 |
| Pubmed | 7.35e-06 | 145 | 64 | 5 | 28846114 | ||
| Pubmed | 7.66e-06 | 551 | 64 | 8 | 34728620 | ||
| Pubmed | The ubiquitin-dependent ATPase p97 removes cytotoxic trapped PARP1 from chromatin. | 8.93e-06 | 400 | 64 | 7 | 35013556 | |
| Pubmed | 9.99e-06 | 3 | 64 | 2 | 33098669 | ||
| Pubmed | 9.99e-06 | 3 | 64 | 2 | 23620591 | ||
| Interaction | SSRP1 interactions | SRRT SAFB CTR9 PBDC1 ANKRD11 ZFR MACROH2A2 CHD3 CHD4 HUWE1 LYAR ATP2B1 PHF10 REXO1 AKAP8L MARCKS AQR | 2.75e-11 | 685 | 64 | 17 | int:SSRP1 |
| Interaction | H2BC4 interactions | NEFM ABCF1 NAA15 PSIP1 AIMP1 ANKRD11 MACROH2A2 MACROH2A1 HUWE1 ATP2B1 HMGN3 | 5.21e-10 | 259 | 64 | 11 | int:H2BC4 |
| Interaction | H3C1 interactions | CYLC2 HMGN5 PLCZ1 BBX PSIP1 DYNC2H1 ANP32B CTR9 CFDP1 CBX1 ZFR MACROH2A2 MACROH2A1 CHD3 CHD4 AQR HDGFL3 | 1.87e-09 | 901 | 64 | 17 | int:H3C1 |
| Interaction | BIRC3 interactions | DHX16 SRRT SAFB ABCF1 PSIP1 AIMP1 DYNC2H1 ANP32B CTR9 RNF20 ZFR MACROH2A1 CHD4 HUWE1 CMYA5 LYAR ATP2B1 ATP2B3 MARCKS AQR | 2.68e-09 | 1334 | 64 | 20 | int:BIRC3 |
| Interaction | H2BC12 interactions | HMGN5 ABCF1 NAA15 ANKRD11 MAP7D2 MACROH2A2 MACROH2A1 CHD3 CHD4 HUWE1 HMGN3 | 5.11e-09 | 322 | 64 | 11 | int:H2BC12 |
| Interaction | H2AC4 interactions | ADGB ACTR8 SVIL CFDP1 RNF20 CBX1 ZFR MACROH2A1 CHD3 CHD4 LYAR ATP2B1 ATP2B3 | 5.52e-09 | 506 | 64 | 13 | int:H2AC4 |
| Interaction | BRD3 interactions | ACTR8 ABCF1 BBX PSIP1 CBX1 MACROH2A2 MACROH2A1 CHD4 LYAR HMGN3 AKAP8L HDGFL3 | 4.25e-08 | 494 | 64 | 12 | int:BRD3 |
| Interaction | CIT interactions | DHX16 NEFM SAFB ABCF1 PSIP1 DYNC2H1 CTR9 SVIL CBX1 ZFR MACROH2A2 MACROH2A1 CHD3 CHD4 CMYA5 LYAR HMGN3 AKAP8L AQR | 6.53e-08 | 1450 | 64 | 19 | int:CIT |
| Interaction | PARP1 interactions | DHX16 HMGN5 NAA15 BBX PSIP1 ANP32B CTR9 SVIL CBX1 MACROH2A2 MACROH2A1 CHD3 CHD4 HUWE1 LYAR PHF10 AQR HDGFL3 | 8.38e-08 | 1316 | 64 | 18 | int:PARP1 |
| Interaction | PYHIN1 interactions | DHX16 TTF2 SAFB ABCF1 CTR9 MACROH2A2 MACROH2A1 CHD4 HUWE1 LYAR | 1.78e-07 | 358 | 64 | 10 | int:PYHIN1 |
| Interaction | HNRNPCL2 interactions | 1.99e-07 | 274 | 64 | 9 | int:HNRNPCL2 | |
| Interaction | CSNK2A1 interactions | DHX16 SRRT SAFB NAA15 PSIP1 ANP32B CTR9 CFDP1 ANKRD11 CBX1 CHD3 CHD4 AQP4 ATP2B1 MARCKS | 2.23e-07 | 956 | 64 | 15 | int:CSNK2A1 |
| Interaction | H2BC21 interactions | PSIP1 CTR9 SVIL CFDP1 RNF20 CBX1 MACROH2A2 MACROH2A1 CHD4 HUWE1 PHF10 HMGN3 ATP2B3 | 2.30e-07 | 696 | 64 | 13 | int:H2BC21 |
| Interaction | ZC3H18 interactions | SRRT SAFB PSIP1 AIMP1 CTR9 ZFR MACROH2A2 MACROH2A1 CHD3 CHD4 CCDC12 LYAR AKAP8L AQR | 4.95e-07 | 877 | 64 | 14 | int:ZC3H18 |
| Interaction | KIF23 interactions | DHX16 SRRT SAFB ABCF1 AIMP1 CDKL2 SVIL MACROH2A2 MACROH2A1 CHD3 CHD4 HUWE1 LYAR ATP2B3 AKAP8L | 5.85e-07 | 1031 | 64 | 15 | int:KIF23 |
| Interaction | OBSL1 interactions | DHX16 SRRT SAFB ABCF1 PSIP1 IGHD AIMP1 CBX1 ZFR MACROH2A2 MACROH2A1 CHD4 HUWE1 AQR | 6.94e-07 | 902 | 64 | 14 | int:OBSL1 |
| Interaction | KIF20A interactions | DHX16 NEFM SAFB ABCF1 PSIP1 DYNC2H1 PTBP2 SVIL MAP7D2 MACROH2A2 MACROH2A1 CHD4 LYAR HMGN3 AKAP8L | 7.55e-07 | 1052 | 64 | 15 | int:KIF20A |
| Interaction | PHF14 interactions | 7.62e-07 | 100 | 64 | 6 | int:PHF14 | |
| Interaction | MYCN interactions | NEFM SRRT SAFB ABCF1 BBX PSIP1 AIMP1 ZFR MACROH2A2 MACROH2A1 CHD4 HUWE1 CCDC12 LYAR AKAP8L MARCKS AQR | 8.52e-07 | 1373 | 64 | 17 | int:MYCN |
| Interaction | CHD4 interactions | SRRT SAFB ABCF1 PSIP1 CTR9 CBX1 ZFR MACROH2A2 MACROH2A1 CHD3 CHD4 LYAR AKAP8L AQR | 1.10e-06 | 938 | 64 | 14 | int:CHD4 |
| Interaction | TERF2IP interactions | DHX16 BBX PSIP1 CFDP1 RNF20 ANKRD11 CBX1 CHD3 PHF10 HMGN3 HDGFL3 | 1.18e-06 | 552 | 64 | 11 | int:TERF2IP |
| Interaction | H2BC9 interactions | ABCF1 PSIP1 SVIL CFDP1 MAP7D2 MACROH2A1 CHD3 CHD4 HMGN3 ATP2B3 | 1.33e-06 | 446 | 64 | 10 | int:H2BC9 |
| Interaction | RBPJ interactions | 1.37e-06 | 254 | 64 | 8 | int:RBPJ | |
| Interaction | TOP1 interactions | DHX16 SRRT SAFB CTR9 CFDP1 ZFR MACROH2A2 MACROH2A1 CHD3 CHD4 CCDC12 PHF10 | 1.66e-06 | 696 | 64 | 12 | int:TOP1 |
| Interaction | H2BC8 interactions | DHX16 BBX PSIP1 CFDP1 CBX1 MACROH2A2 MACROH2A1 CHD3 CHD4 LYAR PHF10 | 1.78e-06 | 576 | 64 | 11 | int:H2BC8 |
| Interaction | NAA40 interactions | DHX16 HMGN5 TTF2 SAFB ABCF1 NAA15 PSIP1 CFDP1 CBX1 ZFR MACROH2A1 CHD3 CHD4 MARCKS | 1.81e-06 | 978 | 64 | 14 | int:NAA40 |
| Interaction | MECP2 interactions | DHX16 NEFM SRRT SAFB ABCF1 BBX PSIP1 PTBP2 CBX1 MACROH2A2 MACROH2A1 CHD4 LYAR AKAP8L MARCKS AQR | 1.84e-06 | 1287 | 64 | 16 | int:MECP2 |
| Interaction | HECTD1 interactions | SRRT ABCF1 PSIP1 AIMP1 ANKRD11 ZFR MACROH2A2 MACROH2A1 CHD3 CHD4 HUWE1 LYAR AKAP8L AQR | 1.94e-06 | 984 | 64 | 14 | int:HECTD1 |
| Interaction | SUMO2 interactions | SRRT SAFB ABCF1 AIMP1 ANP32B CTR9 RNF20 CHD3 CHD4 HUWE1 MARCKS | 2.28e-06 | 591 | 64 | 11 | int:SUMO2 |
| Interaction | H2AZ1 interactions | ABCF1 PSIP1 ANP32B CFDP1 CBX1 MACROH2A2 MACROH2A1 CHD4 PHF10 | 2.49e-06 | 371 | 64 | 9 | int:H2AZ1 |
| Interaction | SRSF6 interactions | 3.88e-06 | 503 | 64 | 10 | int:SRSF6 | |
| Interaction | SIRT6 interactions | SRRT ABCF1 CTR9 RNF20 MAP7D2 MACROH2A1 CHD3 CHD4 HUWE1 AKAP8L AQR | 4.09e-06 | 628 | 64 | 11 | int:SIRT6 |
| Interaction | CBX3 interactions | DHX16 HMGN5 SRRT BBX PSIP1 CFDP1 CBX1 MACROH2A1 CHD3 CHD4 PHF10 | 5.35e-06 | 646 | 64 | 11 | int:CBX3 |
| Interaction | XRCC6 interactions | DHX16 NAA15 BBX PSIP1 CFDP1 CBX1 ZFR MACROH2A2 MACROH2A1 CHD3 CHD4 HUWE1 MARCKS | 5.69e-06 | 928 | 64 | 13 | int:XRCC6 |
| Interaction | FOXE1 interactions | 5.86e-06 | 81 | 64 | 5 | int:FOXE1 | |
| Interaction | RPL15 interactions | BBX AIMP1 MACROH2A2 MACROH2A1 CHD3 CHD4 HUWE1 LYAR PHF10 MARCKS | 6.15e-06 | 530 | 64 | 10 | int:RPL15 |
| Interaction | C17orf78 interactions | 6.58e-06 | 12 | 64 | 3 | int:C17orf78 | |
| Interaction | BRD2 interactions | 8.06e-06 | 429 | 64 | 9 | int:BRD2 | |
| Interaction | PRC1 interactions | SRRT ACTR8 SAFB ABCF1 PSIP1 CBX1 ZFR MACROH2A2 MACROH2A1 CHD4 LYAR HMGN3 AQR | 9.49e-06 | 973 | 64 | 13 | int:PRC1 |
| Interaction | ZNF330 interactions | 1.10e-05 | 446 | 64 | 9 | int:ZNF330 | |
| Interaction | ZBTB2 interactions | 1.18e-05 | 450 | 64 | 9 | int:ZBTB2 | |
| Interaction | SMC5 interactions | SRRT SAFB BBX PSIP1 PTBP2 ANKRD11 CBX1 ZFR MACROH2A1 CHD3 CHD4 LYAR HDGFL3 | 1.27e-05 | 1000 | 64 | 13 | int:SMC5 |
| Interaction | RAD18 interactions | 1.34e-05 | 457 | 64 | 9 | int:RAD18 | |
| Interaction | HSD17B6 interactions | 1.35e-05 | 15 | 64 | 3 | int:HSD17B6 | |
| Interaction | MACROH2A1 interactions | 1.36e-05 | 458 | 64 | 9 | int:MACROH2A1 | |
| Interaction | DDX21 interactions | SRRT SAFB CTR9 ZFR MACROH2A2 CHD3 CHD4 HUWE1 LYAR PHF10 AKAP8L | 1.45e-05 | 718 | 64 | 11 | int:DDX21 |
| Interaction | LUC7L2 interactions | 1.54e-05 | 353 | 64 | 8 | int:LUC7L2 | |
| Interaction | LGR4 interactions | 1.91e-05 | 262 | 64 | 7 | int:LGR4 | |
| Interaction | SNRPA interactions | 2.04e-05 | 482 | 64 | 9 | int:SNRPA | |
| Interaction | H3-3A interactions | DHX16 HMGN5 BBX PSIP1 CFDP1 CBX1 MACROH2A1 CHD3 CHD4 LYAR HDGFL3 | 2.14e-05 | 749 | 64 | 11 | int:H3-3A |
| Interaction | H2BC1 interactions | 2.14e-05 | 178 | 64 | 6 | int:H2BC1 | |
| Interaction | H4C9 interactions | 2.39e-05 | 108 | 64 | 5 | int:H4C9 | |
| Interaction | CENPA interactions | 2.47e-05 | 377 | 64 | 8 | int:CENPA | |
| Interaction | EP300 interactions | DHX16 SRRT SAFB ABCF1 NAA15 PSIP1 AIMP1 PTBP2 CTR9 CFDP1 CBX1 ZFR CHD3 CHD4 LYAR | 2.48e-05 | 1401 | 64 | 15 | int:EP300 |
| Interaction | HDGFL2 interactions | 3.47e-05 | 194 | 64 | 6 | int:HDGFL2 | |
| Interaction | CBX1 interactions | 3.50e-05 | 288 | 64 | 7 | int:CBX1 | |
| Interaction | EED interactions | HMGN5 SRRT ACTR8 SAFB ABCF1 NAA15 ANP32B SVIL ZFR MACROH2A2 MACROH2A1 CHD3 CHD4 HUWE1 AQR | 3.55e-05 | 1445 | 64 | 15 | int:EED |
| Interaction | EFTUD2 interactions | SRRT ABCF1 NAA15 PSIP1 AIMP1 ANP32B CTR9 RNF20 CHD3 CHD4 HUWE1 CCDC12 LYAR MARCKS AQR | 3.66e-05 | 1449 | 64 | 15 | int:EFTUD2 |
| Interaction | HNRNPUL2 interactions | 3.74e-05 | 291 | 64 | 7 | int:HNRNPUL2 | |
| Interaction | MATR3 interactions | 3.82e-05 | 655 | 64 | 10 | int:MATR3 | |
| Interaction | PGAM1 interactions | 4.00e-05 | 199 | 64 | 6 | int:PGAM1 | |
| Interaction | H2BC3 interactions | 4.18e-05 | 406 | 64 | 8 | int:H2BC3 | |
| Interaction | SMC1A interactions | 5.13e-05 | 418 | 64 | 8 | int:SMC1A | |
| Interaction | SNRNP70 interactions | SRRT SAFB ABCF1 BBX PSIP1 ITSN1 ZFR CHD3 CHD4 LYAR AKAP8L AQR | 5.37e-05 | 984 | 64 | 12 | int:SNRNP70 |
| Interaction | RNF8 interactions | 5.40e-05 | 421 | 64 | 8 | int:RNF8 | |
| Interaction | SPTBN1 interactions | 5.40e-05 | 421 | 64 | 8 | int:SPTBN1 | |
| Interaction | NUPR1 interactions | 5.43e-05 | 683 | 64 | 10 | int:NUPR1 | |
| Interaction | KMT2A interactions | 6.05e-05 | 314 | 64 | 7 | int:KMT2A | |
| Interaction | NOS1 interactions | 6.10e-05 | 67 | 64 | 4 | int:NOS1 | |
| Interaction | NUCKS1 interactions | 6.99e-05 | 220 | 64 | 6 | int:NUCKS1 | |
| Interaction | HMGN2 interactions | 7.35e-05 | 222 | 64 | 6 | int:HMGN2 | |
| Interaction | SUPT16H interactions | 7.59e-05 | 442 | 64 | 8 | int:SUPT16H | |
| Interaction | RBBP4 interactions | 7.80e-05 | 573 | 64 | 9 | int:RBBP4 | |
| Interaction | IFI16 interactions | DHX16 SAFB ABCF1 SVIL CBX1 MACROH2A2 MACROH2A1 CHD4 HUWE1 LYAR | 7.86e-05 | 714 | 64 | 10 | int:IFI16 |
| Interaction | RNF2 interactions | ABCF1 CBX1 ZFR MACROH2A1 CHD3 CHD4 HUWE1 LYAR ATP2B1 AKAP8L AQR | 7.99e-05 | 866 | 64 | 11 | int:RNF2 |
| Interaction | RUVBL1 interactions | 8.01e-05 | 575 | 64 | 9 | int:RUVBL1 | |
| Interaction | MEN1 interactions | SRRT ACTR8 SAFB PSIP1 RNF20 ZFR CHD3 CHD4 CCDC12 LYAR AKAP8L AQR | 8.25e-05 | 1029 | 64 | 12 | int:MEN1 |
| Interaction | H2BC5 interactions | 8.42e-05 | 331 | 64 | 7 | int:H2BC5 | |
| Interaction | LILRB4 interactions | 9.45e-05 | 28 | 64 | 3 | int:LILRB4 | |
| Interaction | NR2C2 interactions | DHX16 HMGN5 SAFB ABCF1 AIMP1 CTR9 CBX1 MACROH2A1 CHD4 HUWE1 CCDC12 LYAR AKAP8L AQR | 1.04e-04 | 1403 | 64 | 14 | int:NR2C2 |
| Interaction | GLYR1 interactions | 1.10e-04 | 239 | 64 | 6 | int:GLYR1 | |
| Interaction | RECQL4 interactions | ABCF1 AIMP1 PBDC1 CBX1 PCNX1 ZFR MACROH2A1 CHD3 CHD4 HUWE1 LYAR PHF10 AKAP8L DENR | 1.12e-04 | 1412 | 64 | 14 | int:RECQL4 |
| Interaction | NUMA1 interactions | 1.14e-04 | 469 | 64 | 8 | int:NUMA1 | |
| Interaction | EWSR1 interactions | SRRT SAFB NAA15 PSIP1 ANP32B CFDP1 ZFR CHD3 CHD4 DENR MARCKS | 1.19e-04 | 906 | 64 | 11 | int:EWSR1 |
| Interaction | KPNA1 interactions | 1.21e-04 | 351 | 64 | 7 | int:KPNA1 | |
| Interaction | HNRNPA2B1 interactions | 1.23e-04 | 754 | 64 | 10 | int:HNRNPA2B1 | |
| Interaction | CHD3 interactions | 1.27e-04 | 757 | 64 | 10 | int:CHD3 | |
| Interaction | DDX23 interactions | 1.34e-04 | 480 | 64 | 8 | int:DDX23 | |
| Interaction | CEBPB interactions | SRRT ABCF1 NAA15 PSIP1 AIMP1 ANP32B CTR9 PBDC1 CBX1 ZFR MACROH2A1 CHD4 LYAR AKAP8L | 1.40e-04 | 1443 | 64 | 14 | int:CEBPB |
| Interaction | POLR1G interactions | 1.52e-04 | 489 | 64 | 8 | int:POLR1G | |
| Interaction | WDR5 interactions | SRRT ABCF1 NAA15 PSIP1 AIMP1 CBX1 ZFR MACROH2A1 CHD3 CHD4 LYAR MARCKS | 1.56e-04 | 1101 | 64 | 12 | int:WDR5 |
| Interaction | RCOR1 interactions | 1.63e-04 | 494 | 64 | 8 | int:RCOR1 | |
| Interaction | PRKCSH interactions | 1.64e-04 | 257 | 64 | 6 | int:PRKCSH | |
| Interaction | RNF40 interactions | 1.78e-04 | 261 | 64 | 6 | int:RNF40 | |
| Interaction | LGALS9C interactions | 1.86e-04 | 35 | 64 | 3 | int:LGALS9C | |
| Interaction | HMGN1 interactions | 1.94e-04 | 168 | 64 | 5 | int:HMGN1 | |
| Interaction | KAT6A interactions | 2.03e-04 | 510 | 64 | 8 | int:KAT6A | |
| Interaction | MEX3A interactions | 2.11e-04 | 384 | 64 | 7 | int:MEX3A | |
| Interaction | DOT1L interactions | 2.14e-04 | 807 | 64 | 10 | int:DOT1L | |
| Interaction | SNRPB interactions | 2.23e-04 | 517 | 64 | 8 | int:SNRPB | |
| Cytoband | Xq13.3 | 2.90e-06 | 20 | 64 | 3 | Xq13.3 | |
| Cytoband | 4q24 | 1.04e-03 | 34 | 64 | 2 | 4q24 | |
| Cytoband | 10q22.1 | 1.90e-03 | 46 | 64 | 2 | 10q22.1 | |
| Cytoband | Ensembl 112 genes in cytogenetic band chr4q24 | 3.11e-03 | 59 | 64 | 2 | chr4q24 | |
| GeneFamily | ATPases Ca2+ transporting | 1.12e-06 | 9 | 44 | 3 | 1209 | |
| GeneFamily | Canonical high mobility group | 3.14e-04 | 11 | 44 | 2 | 511 | |
| GeneFamily | PHD finger proteins|NuRD complex | 3.76e-04 | 12 | 44 | 2 | 1305 | |
| GeneFamily | PHD finger proteins | 1.36e-03 | 90 | 44 | 3 | 88 | |
| Coexpression | GSE12845_NAIVE_VS_PRE_GC_TONSIL_BCELL_DN | 9.50e-06 | 200 | 64 | 6 | M3199 | |
| Coexpression | MENON_FETAL_KIDNEY_4_PODOCYTES | 1.12e-05 | 206 | 64 | 6 | M39254 | |
| Coexpression | FOURATI_BLOOD_TWINRIX_AGE_25_83YO_RESPONDERS_VS_POOR_RESPONDERS_0DY_UP | 1.23e-05 | 587 | 64 | 9 | M40869 | |
| Coexpression | BIDUS_METASTASIS_UP | 1.67e-05 | 221 | 64 | 6 | M15866 | |
| Coexpression | OCONNOR_PBMC_MENVEO_ACWYVAX_AGE_30_70YO_7DY_AFTER_SECOND_DOSE_VS_7DY_AFTER_FIRST_DOSE_UP | 2.93e-05 | 146 | 64 | 5 | M41190 | |
| Coexpression | MENON_FETAL_KIDNEY_0_CAP_MESENCHYME_CELLS | 7.05e-05 | 90 | 64 | 4 | M39250 | |
| Coexpression | ZHENG_CORD_BLOOD_C9_GRANULOCYTE_MACROPHAGE_PROGENITOR | 1.06e-04 | 100 | 64 | 4 | M39218 | |
| Coexpression | GSE11864_CSF1_PAM3CYS_VS_CSF1_IFNG_PAM3CYS_IN_MAC_UP | 1.18e-04 | 196 | 64 | 5 | M3148 | |
| Coexpression | GSE43955_1H_VS_10H_ACT_CD4_TCELL_WITH_TGFB_IL6_UP | 1.27e-04 | 199 | 64 | 5 | M9674 | |
| Coexpression | GSE360_L_DONOVANI_VS_B_MALAYI_LOW_DOSE_MAC_DN | 1.27e-04 | 199 | 64 | 5 | M5240 | |
| Coexpression | GSE40655_FOXO1_KO_VS_WT_NTREG_UP | 1.30e-04 | 200 | 64 | 5 | M9439 | |
| Coexpression | GSE37301_MULTIPOTENT_PROGENITOR_VS_RAG2_KO_NK_CELL_DN | 1.30e-04 | 200 | 64 | 5 | M8851 | |
| Coexpression | STARK_PREFRONTAL_CORTEX_22Q11_DELETION_UP | 1.49e-04 | 206 | 64 | 5 | M2817 | |
| Coexpression | STARK_PREFRONTAL_CORTEX_22Q11_DELETION_UP | 1.56e-04 | 208 | 64 | 5 | MM581 | |
| CoexpressionAtlas | FacebaseRNAseq_e8.5_Hind Brain Neural Epithelium_top-relative-expression-ranked_2500_k-means-cluster#3 | 4.03e-06 | 532 | 64 | 10 | Facebase_RNAseq_e8.5_Hind Brain Neural Epithelium_2500_K3 | |
| CoexpressionAtlas | FacebaseRNAseq_e10.5_Neural Epithelium Flanking Eminence_top-relative-expression-ranked_500_k-means-cluster#3 | 2.45e-05 | 192 | 64 | 6 | Facebase_RNAseq_e10.5_Neural Epithelium Flanking Eminence_500_K3 | |
| CoexpressionAtlas | FacebaseRNAseq_e10.5_Neural Epithelium Flanking Eminence_top-relative-expression-ranked_1000 | NEFM LDLRAP1 HMGN5 SAFB ABCF1 NAA15 DYNC2H1 PTBP2 MAP7D2 MACROH2A1 LYAR ATP2B1 | 3.41e-05 | 989 | 64 | 12 | Facebase_RNAseq_e10.5_Neural Epithelium Flanking Eminence_1000 |
| CoexpressionAtlas | FacebaseRNAseq_e8.5_Floor Plate_top-relative-expression-ranked_2500_k-means-cluster#1 | 7.99e-05 | 469 | 64 | 8 | Facebase_RNAseq_e8.5_Floor Plate_2500_K1 | |
| CoexpressionAtlas | facebase_RNAseq_e10.5_Emin_LatNas_2500_K3 | HMGN5 ABCF1 PSIP1 PTBP2 ANP32B PBDC1 RNF20 CBX1 MACROH2A1 CHD4 LYAR MARCKS HDGFL3 | 7.99e-05 | 1257 | 64 | 13 | facebase_RNAseq_e10.5_Emin_LatNas_2500_K3 |
| CoexpressionAtlas | facebase_RNAseq_e10.5_Emin_LatNas_2500 | NEFM HMGN5 ABCF1 PSIP1 PTBP2 ANP32B PBDC1 RNF20 CBX1 MACROH2A1 CHD4 LYAR MARCKS HDGFL3 | 9.08e-05 | 1459 | 64 | 14 | facebase_RNAseq_e10.5_Emin_LatNas_2500 |
| CoexpressionAtlas | FacebaseRNAseq_e10.5_Lateral Nasal Eminence_top-relative-expression-ranked_2500_k-means-cluster#1 | HMGN5 ABCF1 PTBP2 CBX1 MACROH2A1 HUWE1 LYAR PHF10 HMGN3 HDGFL3 | 1.06e-04 | 780 | 64 | 10 | Facebase_RNAseq_e10.5_Lateral Nasal Eminence_2500_K1 |
| CoexpressionAtlas | DevelopingGonad_e12.5_epididymis_emap-29139_top-relative-expression-ranked_1000 | 1.39e-04 | 806 | 64 | 10 | gudmap_developingGonad_e12.5_epididymis_1000 | |
| CoexpressionAtlas | FacebaseRNAseq_e10.5_Neural Epithelium Overlying Lateral Eminence_top-relative-expression-ranked_1000 | NEFM LDLRAP1 HMGN5 SAFB ABCF1 PSIP1 PTBP2 ANP32B ANKRD11 MAP7D2 LYAR | 1.55e-04 | 983 | 64 | 11 | Facebase_RNAseq_e10.5_Neural Epithelium Overlying Lateral Eminence_1000 |
| CoexpressionAtlas | FacebaseRNAseq_e10.5_Neural Epithelium Flanking Eminence_top-relative-expression-ranked_2500_k-means-cluster#5 | NEFM SAFB ABCF1 DYNC2H1 PTBP2 MAP7D2 MACROH2A1 HUWE1 LYAR HMGN3 | 1.78e-04 | 831 | 64 | 10 | Facebase_RNAseq_e10.5_Neural Epithelium Flanking Eminence_2500_K5 |
| CoexpressionAtlas | facebase_RNAseq_e10.5_MandArch_2500_K1 | HMGN5 ABCF1 PSIP1 PTBP2 ANP32B PBDC1 CBX1 CHD4 LYAR PHF10 MARCKS HDGFL3 | 2.92e-04 | 1241 | 64 | 12 | facebase_RNAseq_e10.5_MandArch_2500_K1 |
| CoexpressionAtlas | facebase_RNAseq_e10.5_MaxArch_2500_K3 | NEFM HMGN5 PSIP1 PTBP2 ANP32B CTR9 CBX1 CHD4 LYAR PHF10 MARCKS HDGFL3 | 3.17e-04 | 1252 | 64 | 12 | facebase_RNAseq_e10.5_MaxArch_2500_K3 |
| ToppCell | droplet-Pancreas-PANCREAS-30m-Epithelial-pancreatic_B_cell|Pancreas / Large_Intestine_Pancreas_Liver - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.30e-08 | 195 | 64 | 7 | 3e519cffa6144a62b06124642a14c9ff39b76554 | |
| ToppCell | droplet-Pancreas-PANCREAS-30m-Epithelial-pancreatic_B_cell|Pancreas / Large_Intestine_Pancreas_Liver - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.30e-08 | 195 | 64 | 7 | 7796ea9247f4c63762f0de8490fed08b9717fa23 | |
| ToppCell | E12.5|World / developmental_time, Lineage, Cell group, Cell type, Cell type_cellcyc-phase | 3.62e-07 | 194 | 64 | 6 | 4b335e4da58de1cd94194dc4208ce83854e5e50a | |
| ToppCell | mild_COVID-19_(asymptomatic)-MAIT|World / disease group, cell group and cell class (v2) | 2.76e-06 | 153 | 64 | 5 | 2b4c69f6db17927d6506a645ac058133e60b0103 | |
| ToppCell | PBMC_fresh-frozen-Mild-Moderate_progression_d02_child-Lymphocytic-Lymphocytic_B|Mild-Moderate_progression_d02_child / Compartment, severity and other cell annotations on 10x 3' data (130k) | 3.76e-06 | 163 | 64 | 5 | 6bed27d2f67a430a847da5eb47878d14b4949c45 | |
| ToppCell | PBMC_fresh-frozen-Mild-Moderate_progression_d02_child-Lymphocytic-Lymphocytic_B-B_cell|Mild-Moderate_progression_d02_child / Compartment, severity and other cell annotations on 10x 3' data (130k) | 5.03e-06 | 173 | 64 | 5 | d56e337eae727a29cd53cfd628e1b3c0a98e1f51 | |
| ToppCell | TCGA-Prostate-Primary_Tumor-Prostate_Adenocarcinoma-Acinar_Adenocarcinoma-6|TCGA-Prostate / Sample_Type by Project: Shred V9 | 8.56e-06 | 193 | 64 | 5 | abd71b2cf667ef2b1c4d88acd0c1dd19a12ff659 | |
| ToppCell | 3'-Parenchyma_lung-Immune_Myeloid-Myeloid_macrophage-alveolar_macrophage-Alveolar_macrophages-Alveolar_macrophages_L.1.0.3.0|3' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | 9.23e-06 | 196 | 64 | 5 | a7291291931f9e5abd6a54349bc920a0ab68a4cb | |
| ToppCell | 10x3'2.3-week_14-16-Lymphocytic_B-B_lineage-pre_pro_B_progenitor|week_14-16 / cell types per 3 fetal stages;per 3',per 5' | 9.69e-06 | 198 | 64 | 5 | 8aa4149d2c1cec73cfd654db093252ec8ec5ef68 | |
| ToppCell | 10x5'v1-week_14-16-Lymphocytic_B-B_lineage-pre_pro_B_progenitor|week_14-16 / cell types per 3 fetal stages;per 3',per 5' | 9.93e-06 | 199 | 64 | 5 | 8daf945fc93169b0a4fa3ef9f4a87eedd52e314a | |
| ToppCell | 10x5'v1-week_12-13-Lymphocytic_B-B_lineage|week_12-13 / cell types per 3 fetal stages;per 3',per 5' | 9.93e-06 | 199 | 64 | 5 | ea75804c34989c99aab542e6d72617ed144819b6 | |
| ToppCell | 10x5'v1-week_12-13-Lymphocytic_B|week_12-13 / cell types per 3 fetal stages;per 3',per 5' | 9.93e-06 | 199 | 64 | 5 | 713dfd8552635645db5e0b5721c64e5c9b4aa06c | |
| ToppCell | LPS_only-Mesenchymal_myocytic-Myofibroblastic-Myofibroblast|LPS_only / Treatment groups by lineage, cell group, cell type | 1.02e-05 | 200 | 64 | 5 | 593bf6a7c557437db9a9249a5058a46014179ef6 | |
| ToppCell | 3'_v3-Lung-Lymphocytic_B-Naive_B_cells|Lung / Manually curated celltypes from each tissue | 7.15e-05 | 154 | 64 | 4 | 2b7d7f09c75bbc22de1358fc44b8ad5d3f656617 | |
| ToppCell | frontal_cortex-Neuronal-glutamatergic_neuron-L6_CT|frontal_cortex / Per Region, Lineage, Cell class, Cell type, Cell subtype | 7.51e-05 | 156 | 64 | 4 | fe383ce3a0c37f7343d7026cb51260a04d4c2829 | |
| ToppCell | normal_Lymph_Node-B_lymphocytes-Undetermined|normal_Lymph_Node / Location, Cell class and cell subclass | 8.70e-05 | 162 | 64 | 4 | 91ac35ae7fde411cd6a44e715a33dac62419cab8 | |
| ToppCell | 3'_v3-GI_small-bowel-Lymphocytic_B-Memory_B_cells|GI_small-bowel / Manually curated celltypes from each tissue | 1.00e-04 | 168 | 64 | 4 | 8e025bb0541746e232b77ac0e31412ae71420c47 | |
| ToppCell | 3'_v3-GI_small-bowel-Lymphocytic_B|GI_small-bowel / Manually curated celltypes from each tissue | 1.00e-04 | 168 | 64 | 4 | 5535c1b8b7fde7b59a1bc0580cebdfa963aa1c39 | |
| ToppCell | PND28-Mesenchymal-Mesenchymal_myocytic-Myofibroblast_airway|PND28 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif | 1.02e-04 | 169 | 64 | 4 | 88aa2246ede582c2e11de63228d76f520889ecb3 | |
| ToppCell | PND28-Mesenchymal-Mesenchymal_myocytic-Myofibroblast_airway-ASMC|PND28 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif | 1.02e-04 | 169 | 64 | 4 | a6a5b00912b653fad2ca7f096deaf35c9ef85e5b | |
| ToppCell | PND28-Mesenchymal-Mesenchymal_myocytic-Myofibroblast_airway-ASMC-ASMC_mature|PND28 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif | 1.02e-04 | 169 | 64 | 4 | 42a9b8c77d2a4d68b01e4db38f8a1af53c9c814f | |
| ToppCell | COVID-19-B_cells-Activated_B_cells|COVID-19 / group, cell type (main and fine annotations) | 1.22e-04 | 177 | 64 | 4 | 653bb62a3744d4024ab3186ee01d410ed62832a6 | |
| ToppCell | Severe-B_memory-3|World / disease group and sub_cluster of B and Plasma cells(res = 0.5) | 1.31e-04 | 180 | 64 | 4 | 90b812c5450359b1745b413421b71e291c97086a | |
| ToppCell | PBMC_fresh-frozen-Severe-critical_progression_d12-22_no-steroids|PBMC_fresh-frozen / Compartment, severity and other cell annotations on 10x 3' data (130k) | 1.36e-04 | 182 | 64 | 4 | 862cc68006918e9e46e22b236302d862737f1061 | |
| ToppCell | droplet-Liver-LIVER-NPC-1m-Myeloid-Kupffer_cell|Liver / Large_Intestine_Pancreas_Liver - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.39e-04 | 183 | 64 | 4 | c12a4603cf81b5736553a4530cea5cefab80556f | |
| ToppCell | E12.5-Mesenchymal-developing_mesenchymal_cell-mesenchymal_myogenic_precursor_(Axin2+)|E12.5 / developmental_time, Lineage, Cell group, Cell type, Cell type_cellcyc-phase | 1.39e-04 | 183 | 64 | 4 | 523896bd1a93bdda81a009768baa3a1bdbd108b8 | |
| ToppCell | droplet-Marrow-nan-3m|Marrow / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.42e-04 | 184 | 64 | 4 | 1154a5ad7b8512272b7476f949ddac350910bfb7 | |
| ToppCell | Mild-CD4+_T|Mild / Disease group and Cell class | 1.45e-04 | 185 | 64 | 4 | c28ecb63146de1b02418e5a4fad0ae7c2b66a41d | |
| ToppCell | facs-Brain_Non-Myeloid-Hippocampus-24m-Neuronal-neuron|Brain_Non-Myeloid / Brain_Non-Myeloid_Brain_Myeloid - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.51e-04 | 187 | 64 | 4 | e04a84989d624378141042768383b9c846901f2d | |
| ToppCell | facs-Brain_Non-Myeloid-Hippocampus-24m-Neuronal-nan|Brain_Non-Myeloid / Brain_Non-Myeloid_Brain_Myeloid - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.51e-04 | 187 | 64 | 4 | 24cc03c748e15f7ef0e6509ca5a6ca583fb9c573 | |
| ToppCell | facs-Brain_Non-Myeloid-Hippocampus-24m-Neuronal|Brain_Non-Myeloid / Brain_Non-Myeloid_Brain_Myeloid - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.51e-04 | 187 | 64 | 4 | 2f153b203fe79f206319603cf94d3a03ab49a05d | |
| ToppCell | PBMC_fresh-frozen-Severe-critical_convalescent_d42-56-Lymphocytic-Lymphocytic_B-B_cell-B_c02-MS4A1-CD27|Severe-critical_convalescent_d42-56 / Compartment, severity and other cell annotations on 10x 3' data (130k) | 1.54e-04 | 188 | 64 | 4 | 5707786cc4452dc34f95db2b3cd29f6e025c0622 | |
| ToppCell | E12.5-Mesenchymal|E12.5 / developmental_time, Lineage, Cell group, Cell type, Cell type_cellcyc-phase | 1.54e-04 | 188 | 64 | 4 | 9778dadc2bd7ded3a723e717d1c8cd3160e99c6c | |
| ToppCell | 10x5'v1-week_17-19-Lymphocytic_B-B_lineage-pre_pro_B_progenitor|week_17-19 / cell types per 3 fetal stages;per 3',per 5' | 1.54e-04 | 188 | 64 | 4 | 9858940c616e43441644c5a3bea8d832ee4daf79 | |
| ToppCell | facs-Pancreas-Endocrine-24m-Epithelial-nan|Pancreas / Large_Intestine_Pancreas_Liver - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.54e-04 | 188 | 64 | 4 | 63773854bf8430fb8229edb385b953a89833d08c | |
| ToppCell | PBMC_fresh-frozen-Mild-Moderate_progression_d12-25-Lymphocytic-Lymphocytic_B-B_cell-B_c01-TCL1A|Mild-Moderate_progression_d12-25 / Compartment, severity and other cell annotations on 10x 3' data (130k) | 1.57e-04 | 189 | 64 | 4 | b13f315f617840eb5143a4e8a33a657c20365c21 | |
| ToppCell | PBMC_fresh-frozen-Severe-critical_progression_d12-22_with-steroid-Lymphocytic-Lymphocytic_B-B_cell|Severe-critical_progression_d12-22_with-steroid / Compartment, severity and other cell annotations on 10x 3' data (130k) | 1.57e-04 | 189 | 64 | 4 | 886dceacf96e2b6750c146a381da0bf96a2bb15b | |
| ToppCell | E16.5-Mesenchymal-Mesenchymal_structural-Fibroblastic-PMP-PMP_mature|E16.5 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif | 1.57e-04 | 189 | 64 | 4 | 3169476f98b7385706cb618c9ad64ae83a290ef0 | |
| ToppCell | RV-15._Ventricular_Cardiomyocyte_III|World / Chamber and Cluster_Paper | 1.57e-04 | 189 | 64 | 4 | 0a82931b5f6c0a6427ca3edd5e2235ac49099d40 | |
| ToppCell | PBMC_fresh-frozen-Severe-critical_progression_d12-22_with-steroid-Lymphocytic-Lymphocytic_B|Severe-critical_progression_d12-22_with-steroid / Compartment, severity and other cell annotations on 10x 3' data (130k) | 1.57e-04 | 189 | 64 | 4 | 5f1f4321939877374a8ee13de93f2d1390af8e2e | |
| ToppCell | droplet-Large_Intestine-COLON_PROXIMAL-30m-Epithelial-Lgr5-_amplifying_undifferentiated_cell|Large_Intestine / Large_Intestine_Pancreas_Liver - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.61e-04 | 190 | 64 | 4 | 36e83995021ba16690f84e2077a9e8baec547d05 | |
| ToppCell | RV-15._Ventricular_Cardiomyocyte_III|RV / Chamber and Cluster_Paper | 1.61e-04 | 190 | 64 | 4 | 93c3188dfeb0b2f9889f8ae9b9c1f2f34129c99b | |
| ToppCell | PBMC_fresh-frozen-Severe-critical_progression_d12-22_with-steroid-Lymphocytic-Lymphocytic_B-B_cell-B_c01-TCL1A|Severe-critical_progression_d12-22_with-steroid / Compartment, severity and other cell annotations on 10x 3' data (130k) | 1.61e-04 | 190 | 64 | 4 | 60bb6aaea9691d07295f61c14d1650f5041a0f9c | |
| ToppCell | PND10|World / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif | 1.61e-04 | 190 | 64 | 4 | d67e2814047c8df2ae4b7bc8be9539f5df6ecef2 | |
| ToppCell | droplet-Large_Intestine-COLON_PROXIMAL-30m-Epithelial-epithelial_cell_of_large_intestine|Large_Intestine / Large_Intestine_Pancreas_Liver - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.61e-04 | 190 | 64 | 4 | d26be9e1b676f750e716b91ebc3598fac3735612 | |
| ToppCell | droplet-Large_Intestine-COLON_PROXIMAL|Large_Intestine / Large_Intestine_Pancreas_Liver - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.64e-04 | 191 | 64 | 4 | 60c986d2dcbc19d9338c03da6cb5e1d92fd48f8e | |
| ToppCell | PBMC-Convalescent-Lymphocyte-B-B_cell|Convalescent / Location, Disease Group, Cell group, Cell class (2021.03.09) | 1.64e-04 | 191 | 64 | 4 | 07b03739db24c7d834300de63ef1847724cba684 | |
| ToppCell | droplet-Large_Intestine-COLON_PROXIMAL-30m-Epithelial|Large_Intestine / Large_Intestine_Pancreas_Liver - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.64e-04 | 191 | 64 | 4 | 09db184cb90fe282a14474d7217068c58092c6f8 | |
| ToppCell | droplet-Large_Intestine-COLON_PROXIMAL-30m|Large_Intestine / Large_Intestine_Pancreas_Liver - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.64e-04 | 191 | 64 | 4 | 973117730d6ba5f127e7a0bfabfd0ff2ca7ac131 | |
| ToppCell | E15.5|World / developmental_time, Lineage, Cell group, Cell type, Cell type_cellcyc-phase | 1.67e-04 | 192 | 64 | 4 | 4a0fb4ef8a9281489ffb0881421c9d691c52019c | |
| ToppCell | 356C-Lymphocytic-B_cell|Lymphocytic / Donor, Lineage, Cell class and subclass (all cells) | 1.67e-04 | 192 | 64 | 4 | f1ac7fa8159f573d140f0e4cbd15256dcb142980 | |
| ToppCell | 356C-Lymphocytic-B_cell-|Lymphocytic / Donor, Lineage, Cell class and subclass (all cells) | 1.67e-04 | 192 | 64 | 4 | 1d7a5d15c76ae45551ce104327a2241fbf7d1827 | |
| ToppCell | PBMC_fresh-frozen-Mild-Moderate_progression_d02_child-Lymphocytic-Lymphocytic_B-B_cell-B_c02-MS4A1-CD27|Mild-Moderate_progression_d02_child / Compartment, severity and other cell annotations on 10x 3' data (130k) | 1.71e-04 | 193 | 64 | 4 | 08696a99309f5b088692ddac8cca35413b5e810d | |
| ToppCell | COVID-19-Heart-CM_+_EC_+_Pericyte|Heart / Disease (COVID-19 only), tissue and cell type | 1.71e-04 | 193 | 64 | 4 | dd5378a1ef8eb0eda9a3aae62f3c2f3a1402bda0 | |
| ToppCell | PBMC_fresh-frozen-Severe-critical_convalescent_d14-21-Lymphocytic-Lymphocytic_B|Severe-critical_convalescent_d14-21 / Compartment, severity and other cell annotations on 10x 3' data (130k) | 1.71e-04 | 193 | 64 | 4 | 89831e1007944e47719e58f23bfef5f1944cae23 | |
| ToppCell | PBMC-Convalescent-Lymphocyte-B-B_cell-B_intermediate-|Convalescent / Location, Disease Group, Cell group, Cell class and sub_cluster (2021.03.09) | 1.71e-04 | 193 | 64 | 4 | 437ae3b10d169bb371f7b92d57a77f43e3f8d64d | |
| ToppCell | PBMC-Convalescent-Lymphocyte-B-B_cell-B_intermediate|Convalescent / Location, Disease Group, Cell group, Cell class (2021.03.09) | 1.71e-04 | 193 | 64 | 4 | 94b5a4a4e9faaa95cb72907a2f0497429c72e516 | |
| ToppCell | Smart-seq2-lymph_node_(Smart-seq2)-lymphocytic-B_lymphocytic-B_cell|lymph_node_(Smart-seq2) / Per Platform+tissue_group, by lineage_subgroup, cell_group, cell_type | 1.74e-04 | 194 | 64 | 4 | ff661419b697aef51a53fdeac8d37d870d65f491 | |
| ToppCell | PBMC_fresh-frozen-Mild-Moderate_progression_d12-25-Lymphocytic-Lymphocytic_B-B_cell-B_c02-MS4A1-CD27|Mild-Moderate_progression_d12-25 / Compartment, severity and other cell annotations on 10x 3' data (130k) | 1.74e-04 | 194 | 64 | 4 | d852aebf7a763b9a776c4570711f0c759f591910 | |
| ToppCell | PBMC_fresh-frozen-Severe-critical_convalescent_d14-21-Lymphocytic-Lymphocytic_B-B_cell|Severe-critical_convalescent_d14-21 / Compartment, severity and other cell annotations on 10x 3' data (130k) | 1.74e-04 | 194 | 64 | 4 | 1b9ec27cdd52a54b55e4ad89162e8a170d57c017 | |
| ToppCell | PBMC_fresh-frozen-Mild-Moderate_progression_d12-25-Lymphocytic-Lymphocytic_B-B_cell|Mild-Moderate_progression_d12-25 / Compartment, severity and other cell annotations on 10x 3' data (130k) | 1.77e-04 | 195 | 64 | 4 | 481989d2e5bd2582da3d86b0155c4d6615317067 | |
| ToppCell | PBMC_fresh-frozen-Mild-Moderate_progression_d12-25-Lymphocytic-Lymphocytic_B|Mild-Moderate_progression_d12-25 / Compartment, severity and other cell annotations on 10x 3' data (130k) | 1.77e-04 | 195 | 64 | 4 | 6108a27523d1b93a7fbe35cb95704a5ad9071e3c | |
| ToppCell | Mild/Remission-B_memory-0|World / disease group and sub_cluster of B and Plasma cells(res = 0.5) | 1.77e-04 | 195 | 64 | 4 | 3c51f005d8546c570752f5f0ce6b8ac242d3c54b | |
| ToppCell | Macrophages-Donor_03|World / lung cells shred on cell class, cell subclass, sample id | 1.77e-04 | 195 | 64 | 4 | e48bf57e6da23fbb4637a02387155f825455c49f | |
| ToppCell | COVID-19_Severe-Lymphoid_T/NK-gd_T|COVID-19_Severe / Disease group, lineage and cell class | 1.77e-04 | 195 | 64 | 4 | 9990440bda7fac5d00ef80444fab07459be625e1 | |
| ToppCell | PBMC-Severe-Lymphocyte-T/NK-Other_T-gd_T|Severe / Location, Disease Group, Cell group, Cell class (2021.03.09) | 1.81e-04 | 196 | 64 | 4 | 418e8e0a51c5cb60e3b903e7d2d800dc8b9f3d5c | |
| ToppCell | PBMC-Severe-Lymphocyte-T/NK-Other_T-gd_T-|Severe / Location, Disease Group, Cell group, Cell class and sub_cluster (2021.03.01) | 1.81e-04 | 196 | 64 | 4 | 581fc8c8d42005aacd7b401a2c9d1fc331fb4af7 | |
| ToppCell | PBMC-Severe-Lymphocyte-T/NK-Other_T-gd_T-|Severe / Location, Disease Group, Cell group, Cell class and sub_cluster (2021.03.09) | 1.81e-04 | 196 | 64 | 4 | 6beaf0c2799424c59819b286fbb5c1a83d85e4d1 | |
| ToppCell | PBMC-Severe-Lymphocyte-T/NK-Other_T-gd_T|Severe / Location, Disease Group, Cell group, Cell class and sub_cluster (2021.03.01) | 1.81e-04 | 196 | 64 | 4 | c35f2349dfe35baa845f790b9f31673dceac54c0 | |
| ToppCell | severe-B_intermediate|severe / disease stage, cell group and cell class | 1.81e-04 | 196 | 64 | 4 | 8f59e51ca50bef4753f67cd1efdb02665805a120 | |
| ToppCell | PND01-Mesenchymal-Mesenchymal_myocytic-Myofibroblast_vascular|PND01 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif | 1.81e-04 | 196 | 64 | 4 | 6708026bafd19c35c5c4e81911344d36a0f508cd | |
| ToppCell | 10x5'v1-week_14-16-Lymphocytic_B|week_14-16 / cell types per 3 fetal stages;per 3',per 5' | 1.84e-04 | 197 | 64 | 4 | 31dfd9842410b5c629f39b5130233995dceb0aef | |
| ToppCell | 10x5'v1-week_14-16-Lymphocytic_B-B_lineage|week_14-16 / cell types per 3 fetal stages;per 3',per 5' | 1.84e-04 | 197 | 64 | 4 | 7290f05d0b8465637420119941bcbf2fae44a7e4 | |
| ToppCell | H1299-infected-SARSCoV2|infected / Cell line, Condition and Strain | 1.84e-04 | 197 | 64 | 4 | 0fa3e4cf93e77d78b1f97b906c5b13ca741ae17e | |
| ToppCell | lymphoid-T_cell|lymphoid / Lineage, cell class and subclass | 1.88e-04 | 198 | 64 | 4 | 41573038b34803f664a7cb5a7d05b8afdff55b58 | |
| ToppCell | Severe-B_memory-3|Severe / disease group and sub_cluster of B and Plasma cells(res = 0.5) | 1.88e-04 | 198 | 64 | 4 | a3050c126799e32f742a14396236572250476820 | |
| ToppCell | Immune_cells-large_pre-B.|Immune_cells / Lineage and Cell class | 1.88e-04 | 198 | 64 | 4 | bc9ceefadb153907d2854d1f736d17349003cb31 | |
| ToppCell | 10x5'v1-week_12-13-Lymphocytic_B-B_lineage-pre_pro_B_progenitor|week_12-13 / cell types per 3 fetal stages;per 3',per 5' | 1.92e-04 | 199 | 64 | 4 | 5478b78349b5d8d57f30bb650dcbd5fdb84283d6 | |
| ToppCell | (10)_Ciliated-(2)_GFP_FOXI1|(10)_Ciliated / shred by cell type by condition | 1.92e-04 | 199 | 64 | 4 | 61b1ed2db71b96157b92b7535d1955a4033098da | |
| ToppCell | (00)_Basal-(2)_GFP_FOXI1|(00)_Basal / shred by cell type by condition | 1.92e-04 | 199 | 64 | 4 | 19674e1eaeb51e4196d847cb62aa437c852951d3 | |
| ToppCell | LPS_anti-TNF-Mesenchymal_myocytic-Myofibroblastic|LPS_anti-TNF / Treatment groups by lineage, cell group, cell type | 1.92e-04 | 199 | 64 | 4 | e9820d5fb4e8b46973c4c50ac5db8fb4a1bf603b | |
| ToppCell | (09)_Interm._secr.>cil.-(2)_GFP_FOXI1|(09)_Interm._secr.>cil. / shred by cell type by condition | 1.92e-04 | 199 | 64 | 4 | fc680f85ebd3bab4c72876a19a461b0afb5f51ce | |
| ToppCell | mild-CD4+_T_naive|World / Cohort 1 (10x PBMC) with disease condition, cell group and cell class | 1.92e-04 | 199 | 64 | 4 | 3e4baaf4ee23f257d821194468102c00a8ad2f21 | |
| ToppCell | Neuron-Postmitotic-Excitatory_Neuron_-Parietal_and_Temporal-6|World / Primary Cells by Cluster | 1.92e-04 | 199 | 64 | 4 | 1b1bccf4293f11048709d15a3c892c0edf3da3d2 | |
| ToppCell | 3'-GW_trimst-1|3' / Celltypes from developing, pediatric, Crohn's, & adult GI tract | 1.92e-04 | 199 | 64 | 4 | ecfb6381e2971a3e355e661a6df0021914485e74 | |
| ToppCell | (05)_Secretory-(2)_GFP_FOXI1|(05)_Secretory / shred by cell type by condition | 1.92e-04 | 199 | 64 | 4 | d72d87e1e530ed894c0ad5e7b5b2b1d6b59fa098 | |
| ToppCell | Neuron-Postmitotic-Excitatory_Neuron_-Parietal_and_Temporal|World / Primary Cells by Cluster | 1.92e-04 | 199 | 64 | 4 | 4bee94c116c0da5eba951cb4cea7cc9dcdd6e30f | |
| ToppCell | Frontal_cortex-Neuronal|Frontal_cortex / BrainAtlas - Mouse McCarroll V32 | 1.92e-04 | 199 | 64 | 4 | f88039d862f3bfa01dc39d2de4f3f548dc5a0e61 | |
| ToppCell | Control-Control-Lymphocyte-T/NK-dn_T|Control / Disease, condition lineage and cell class | 1.95e-04 | 200 | 64 | 4 | 10882c59b7aaf8bd4b5c00aa4ddbb9f7ac5b2cf5 | |
| ToppCell | Sepsis-Int-URO-Lymphocyte-T/NK-CD8+_Tcm|Int-URO / Disease, condition lineage and cell class | 1.95e-04 | 200 | 64 | 4 | 9535fd16a962d57e80319bc26093617e04c8b2a8 | |
| ToppCell | LPS_anti-TNF-Mesenchymal_myocytic-Myofibroblastic-Myofibroblast|LPS_anti-TNF / Treatment groups by lineage, cell group, cell type | 1.95e-04 | 200 | 64 | 4 | c596a53c0b63c9deaac7d99fcbdd94ecfa96b86c | |
| ToppCell | Non-neuronal-Dividing-IPC-IPC-div2|World / Primary Cells by Cluster | 1.95e-04 | 200 | 64 | 4 | 4923d7a4f00853c4d76fc1cc0fa82d522a2302e7 | |
| ToppCell | Non-neuronal-Dividing-IPC-IPC-div2-5|World / Primary Cells by Cluster | 1.95e-04 | 200 | 64 | 4 | dc1c1506823eaa105f1532c6b5d4efa14e788314 | |
| ToppCell | LPS_only-Mesenchymal_myocytic-Myofibroblastic|LPS_only / Treatment groups by lineage, cell group, cell type | 1.95e-04 | 200 | 64 | 4 | 02cae2c296a13ad4cbb53bca7a86d64629d67d66 | |
| ToppCell | lymphoid-B_cell-Naive_B_cell|B_cell / Lineage, cell class and subclass | 2.09e-04 | 80 | 64 | 3 | dd2ecd244cd2cf770ada756ac96e34afc3301772 | |
| ToppCell | 367C-Lymphocytic-NK_cells-NK_cell_A|NK_cells / Donor, Lineage, Cell class and subclass (all cells) | 2.86e-04 | 89 | 64 | 3 | d8832dbe69d3490ceaa05ccc99d7c81707803925 | |
| Drug | gramicidin s | 6.09e-08 | 37 | 64 | 5 | CID000073357 | |
| Drug | Clozapine [5786-21-0]; Up 200; 12.2uM; PC3; HT_HG-U133A | 1.16e-06 | 193 | 64 | 7 | 4670_UP | |
| Drug | 1sqc | 2.51e-06 | 10 | 64 | 3 | CID000444279 | |
| Drug | 2,5-dimethylquinone | 3.44e-06 | 11 | 64 | 3 | CID000008718 | |
| Drug | 1vyq | 4.58e-06 | 12 | 64 | 3 | CID004369390 | |
| Drug | Ro 46861 | 4.58e-06 | 12 | 64 | 3 | CID000003128 | |
| Drug | 8-hydroxycoumarin | 5.94e-06 | 13 | 64 | 3 | CID000122783 | |
| Drug | p-hydroxyhippuric acid | 7.54e-06 | 14 | 64 | 3 | CID000151012 | |
| Drug | caloxin 1b1 | 7.78e-06 | 2 | 64 | 2 | ctd:C510327 | |
| Drug | Captopril [62571-86-2]; Down 200; 17.2uM; PC3; HT_HG-U133A | 1.12e-05 | 179 | 64 | 6 | 4585_DN | |
| Drug | AC1L88YH | 1.40e-05 | 17 | 64 | 3 | CID000374551 | |
| Drug | 1,4-dibromobutane | 1.50e-05 | 53 | 64 | 4 | CID000008056 | |
| Drug | Acemetacin [53164-05-9]; Up 200; 9.6uM; MCF7; HT_HG-U133A | 1.76e-05 | 194 | 64 | 6 | 7442_UP | |
| Drug | radicicol; Up 200; 0.1uM; MCF7; HG-U133A | 1.81e-05 | 195 | 64 | 6 | 325_UP | |
| Drug | Ticarcillin sodium [4697-14-7]; Down 200; 9.4uM; MCF7; HT_HG-U133A | 1.92e-05 | 197 | 64 | 6 | 7185_DN | |
| Drug | Mianserine hydrochloride [21535-47-7]; Up 200; 13.2uM; HL60; HG-U133A | 1.92e-05 | 197 | 64 | 6 | 1385_UP | |
| Drug | Saquinavir mesylate [149845-06-7]; Up 200; 5.2uM; HL60; HT_HG-U133A | 1.98e-05 | 198 | 64 | 6 | 6127_UP | |
| Drug | Clomipramine hydrochloride [17321-77-6]; Down 200; 11.4uM; HL60; HG-U133A | 1.98e-05 | 198 | 64 | 6 | 1566_DN | |
| Drug | raloxifene hydrochloride; Down 200; 0.1uM; HL60; HG-U133A | 1.98e-05 | 198 | 64 | 6 | 388_DN | |
| Drug | Famotidine [76824-35-6]; Up 200; 11.8uM; MCF7; HT_HG-U133A | 1.98e-05 | 198 | 64 | 6 | 1529_UP | |
| Drug | Meclozine dihydrochloride [1104-22-9]; Up 200; 8.6uM; PC3; HT_HG-U133A | 2.09e-05 | 200 | 64 | 6 | 4646_UP | |
| Drug | 2brh | 2.72e-05 | 21 | 64 | 3 | CID000848641 | |
| Drug | AC1L25Y6 | 3.60e-05 | 23 | 64 | 3 | CID000015465 | |
| Drug | lanthanum chloride hydrate | 3.60e-05 | 23 | 64 | 3 | CID000165791 | |
| Drug | chlordecone | 3.81e-05 | 67 | 64 | 4 | CID000000299 | |
| Drug | cyhexatin | 4.66e-05 | 25 | 64 | 3 | CID005364545 | |
| Drug | monobromobimane | 5.06e-05 | 72 | 64 | 4 | CID000114810 | |
| Drug | dodecyl ether | 5.26e-05 | 26 | 64 | 3 | CID000020667 | |
| Drug | MgCl2 | 6.01e-05 | 354 | 64 | 7 | CID000024584 | |
| Drug | compound 48/80 | 6.68e-05 | 151 | 64 | 5 | CID000104735 | |
| Drug | W7 hydrochloride | 7.26e-05 | 250 | 64 | 6 | CID000005681 | |
| Drug | octaethylene glycol | 7.35e-05 | 29 | 64 | 3 | CID000078798 | |
| Drug | 1tkz | 7.74e-05 | 5 | 64 | 2 | CID000448727 | |
| Drug | gibberellin (GA | 1.04e-04 | 166 | 64 | 5 | CID000006466 | |
| Drug | AC1MHXFF | 1.16e-04 | 6 | 64 | 2 | CID003013152 | |
| Drug | fluorescamine | 1.30e-04 | 35 | 64 | 3 | CID000037927 | |
| Drug | mag-fura-2 | 1.54e-04 | 37 | 64 | 3 | CID000123839 | |
| Drug | Primaquine diphosphate [63-45-6]; Down 200; 8.8uM; MCF7; HT_HG-U133A | 1.87e-04 | 188 | 64 | 5 | 4845_DN | |
| Drug | Flupentixol dihydrochloride cis-(Z) [2413-38-9]; Down 200; 7.8uM; HL60; HT_HG-U133A | 1.92e-04 | 189 | 64 | 5 | 1288_DN | |
| Drug | carbidine | 1.94e-04 | 40 | 64 | 3 | CID000065684 | |
| Drug | Sulfamethazine sodium salt [1981-58-4]; Down 200; 13.4uM; PC3; HT_HG-U133A | 1.96e-04 | 190 | 64 | 5 | 4322_DN | |
| Drug | WY-14643; Down 200; 100uM; PC3; HG-U133A | 2.06e-04 | 192 | 64 | 5 | 464_DN | |
| Drug | Quercetine dihydrate [6151-25-3]; Down 200; 11.8uM; MCF7; HT_HG-U133A | 2.11e-04 | 193 | 64 | 5 | 4846_DN | |
| Drug | Felodipine [72509-76-3]; Down 200; 10.4uM; HL60; HT_HG-U133A | 2.16e-04 | 194 | 64 | 5 | 2433_DN | |
| Drug | BW-B 70C; Down 200; 31.6uM; MCF7; HT_HG-U133A_EA | 2.22e-04 | 195 | 64 | 5 | 1132_DN | |
| Drug | C12E8 | 2.25e-04 | 42 | 64 | 3 | CID000123921 | |
| Drug | Benzylpenicillin sodium [69-57-8]; Down 200; 11.2uM; HL60; HT_HG-U133A | 2.27e-04 | 196 | 64 | 5 | 6155_DN | |
| Drug | Pheniramine maleate [132-20-7]; Up 200; 11.2uM; HL60; HG-U133A | 2.32e-04 | 197 | 64 | 5 | 1992_UP | |
| Drug | Chlorpheniramine maleate [113-92-8]; Up 200; 10.2uM; HL60; HG-U133A | 2.32e-04 | 197 | 64 | 5 | 1371_UP | |
| Drug | ICI 182,780; Up 200; 1uM; HL60; HT_HG-U133A | 2.38e-04 | 198 | 64 | 5 | 6165_UP | |
| Drug | Urapidil hydrochloride [64887-14-5]; Up 200; 9.4uM; MCF7; HT_HG-U133A | 2.38e-04 | 198 | 64 | 5 | 5295_UP | |
| Drug | (1-[(4-Chlorophenyl)phenyl-methyl]-4-methylpiperazine) [1620-21-9]; Down 200; 11.8uM; MCF7; HT_HG-U133A | 2.38e-04 | 198 | 64 | 5 | 4367_DN | |
| Drug | ionomycin calcium salt; Down 200; 2uM; MCF7; HT_HG-U133A_EA | 2.38e-04 | 198 | 64 | 5 | 871_DN | |
| Drug | Naftifine hydrochloride [65473-14-5]; Down 200; 12.4uM; MCF7; HT_HG-U133A | 2.38e-04 | 198 | 64 | 5 | 7032_DN | |
| Drug | linopirdine | 2.41e-04 | 43 | 64 | 3 | CID000003932 | |
| Drug | Kanamycin A sulfate [25389-94-0]; Down 200; 6.8uM; MCF7; HT_HG-U133A | 2.43e-04 | 199 | 64 | 5 | 3224_DN | |
| Drug | Pyrantel tartrate [33401-94-4]; Up 200; 11.2uM; MCF7; HT_HG-U133A | 2.49e-04 | 200 | 64 | 5 | 5513_UP | |
| Drug | halothane | 2.51e-04 | 314 | 64 | 6 | CID000003562 | |
| Drug | butyrate | HMGN5 SAFB PSIP1 MACROH2A2 MACROH2A1 ATP2B1 HMGN3 ATP2B3 ATP2B4 | 2.80e-04 | 767 | 64 | 9 | CID000000264 |
| Drug | agelasine B | 2.95e-04 | 46 | 64 | 3 | CID006439899 | |
| Disease | Hailey-Hailey disease (implicated_via_orthology) | 1.76e-07 | 6 | 62 | 3 | DOID:0050429 (implicated_via_orthology) | |
| Disease | chronic obstructive pulmonary disease, coronary artery disease | 2.60e-05 | 4 | 62 | 2 | EFO_0000341, EFO_0001645 | |
| Disease | Vasodilators used in cardiac diseases use measurement | 5.05e-05 | 34 | 62 | 3 | EFO_0009926 | |
| Disease | coronary artery disease, factor VII measurement | 8.94e-05 | 111 | 62 | 4 | EFO_0001645, EFO_0004619 | |
| Disease | factor VIII measurement, coronary artery disease | 9.58e-05 | 113 | 62 | 4 | EFO_0001645, EFO_0004630 | |
| Disease | factor XI measurement, coronary artery disease | 1.03e-04 | 115 | 62 | 4 | EFO_0001645, EFO_0004694 | |
| Disease | X-Linked Csnb | 2.83e-04 | 12 | 62 | 2 | C3711543 | |
| Disease | Night blindness, congenital stationary, type 1 | 2.83e-04 | 12 | 62 | 2 | C3501847 | |
| Disease | Night Blindness, Congenital Stationary, Type 1A | 2.83e-04 | 12 | 62 | 2 | C3495587 | |
| Disease | NIGHT BLINDNESS, CONGENITAL STATIONARY, TYPE 2B (disorder) | 2.83e-04 | 12 | 62 | 2 | C1864877 | |
| Disease | NIGHT BLINDNESS, CONGENITAL STATIONARY, TYPE 2A | 2.83e-04 | 12 | 62 | 2 | C1848172 | |
| Disease | NIGHT BLINDNESS, CONGENITAL STATIONARY, TYPE 1B | 2.83e-04 | 12 | 62 | 2 | C1850362 | |
| Disease | coronary artery disease, plasminogen activator inhibitor 1 measurement | 3.21e-04 | 63 | 62 | 3 | EFO_0001645, EFO_0004792 | |
| Disease | Cone-rod synaptic disorder, congenital nonprogressive | 3.34e-04 | 13 | 62 | 2 | C4041558 | |
| Disease | tissue plasminogen activator measurement, coronary artery disease | 4.56e-04 | 71 | 62 | 3 | EFO_0001645, EFO_0004791 | |
| Disease | Night blindness, congenital stationary | 5.79e-04 | 17 | 62 | 2 | C0339535 | |
| Disease | autism spectrum disorder, schizophrenia | 6.26e-04 | 327 | 62 | 5 | EFO_0003756, MONDO_0005090 | |
| Disease | migraine disorder, pulse pressure measurement | 1.37e-03 | 26 | 62 | 2 | EFO_0005763, MONDO_0005277 | |
| Disease | lumbar disc degeneration | 1.59e-03 | 28 | 62 | 2 | EFO_0004994 | |
| Disease | selenium measurement | 1.70e-03 | 29 | 62 | 2 | EFO_0006331 | |
| Disease | von Willebrand factor measurement, coronary artery disease | 1.99e-03 | 118 | 62 | 3 | EFO_0001645, EFO_0004629 | |
| Disease | calcium measurement | 2.03e-03 | 628 | 62 | 6 | EFO_0004838 |
| Peptide | Gene | Start | Entry |
|---|---|---|---|
| RQETGDEPKGEKEKK | 551 | Q8NDB2 | |
| RGEEKKGKDQSGEVL | 306 | P55087 | |
| KGRRKKDVDDDGEEK | 81 | Q8NE71 | |
| GKDKERKASLDQGKE | 1071 | Q6UB99 | |
| AEKKEKGEDYKEGGS | 1371 | Q6UB99 | |
| EKGKHDDGRKKEAEI | 611 | Q5VTR2 | |
| KESDGGRIKELEKGK | 321 | Q8WY36 | |
| GKEGKEGKEIKDGKE | 321 | Q8N7X0 | |
| KGDTENGKEKGGEKE | 6 | Q9H981 | |
| NGKEKGGEKEKEQRG | 11 | Q9H981 | |
| EQIKGGTGDEKKAKE | 111 | Q12904 | |
| KEDIGKALEKAGGKE | 226 | Q9P0M6 | |
| KDDLGNTLEKKGGKE | 226 | O75367 | |
| SEGEKGGTEKDSKKG | 206 | Q14093 | |
| GKGKKRKDADVEDED | 756 | O60306 | |
| EEEGGKGEKRKRETD | 231 | Q92688 | |
| NLKDAGEAEEGKRDK | 386 | P10523 | |
| EEEEASEKGKKKTGG | 136 | O60231 | |
| LGAGGEEEEKKDEKK | 291 | P20020 | |
| LKSEEGGDGDEKDKK | 336 | P20020 | |
| LLGAGGEEEEKKDKK | 291 | Q16720 | |
| GEEEEKKDKKGKQQD | 296 | Q16720 | |
| LLGVNEDDEGEKKKK | 286 | P23634 | |
| KEDGREEGKEDPEKG | 336 | Q9ULX6 | |
| KEEKEKRDKASQEGG | 176 | Q5SW96 | |
| AGTAKDKGGEKSNEK | 766 | O60840 | |
| KLLKEEEDEKERGGG | 86 | O75121 | |
| KKQEGEEKRKAGEEA | 466 | Q96T17 | |
| LKSDIGDKGKNKDEG | 66 | Q9BPX6 | |
| DSKVRKDVGGKQKEG | 526 | Q96RV3 | |
| AVDKKEAGKDGRGEE | 166 | P29536 | |
| KEEGINREDKTDKGG | 201 | Q9BVG4 | |
| NREDKTDKGGEKGKE | 206 | Q9BVG4 | |
| TDKGGEKGKEADKEI | 211 | Q9BVG4 | |
| EKGKEADKEINKSGE | 216 | Q9BVG4 | |
| KGKKEEKQEAGKEGT | 61 | Q15651 | |
| KGEAGKEDKDEKGEE | 141 | P82970 | |
| DGKEDKNGNEKGEDA | 156 | P82970 | |
| KNGNEKGEDAKEKED | 161 | P82970 | |
| KEKEDGKKGEDGKGN | 171 | P82970 | |
| DRKETGDGKENEDGK | 201 | P82970 | |
| GDGKENEDGKEKGDK | 206 | P82970 | |
| NEDGKEKGDKKEGKD | 211 | P82970 | |
| GKNGDSAERGKEKKA | 551 | Q8TE49 | |
| GDRVEEDGKGKRKNE | 126 | Q9Y3E1 | |
| DGKKDKEGDRASEEG | 2041 | Q7Z6Z7 | |
| KEGDRASEEGKQKGK | 2046 | Q7Z6Z7 | |
| KKKDDDDEEIGGPKE | 626 | Q9BXJ9 | |
| DGRGDEKRKNKGTSD | 306 | Q8WUB8 | |
| IKGSKIDGEKAEKGN | 356 | Q92772 | |
| ETGGGEKYNDKKRKE | 2826 | Q8NCM8 | |
| QEKGIGSEDARKKKE | 96 | Q9UEE9 | |
| EEGKEESKGEKEKEG | 786 | Q05DH4 | |
| GSGEDDGKSDKRKVK | 596 | Q12873 | |
| KDQGQGLEEKRVGKD | 3256 | Q8N3K9 | |
| KDGEEKGKQEAQDKL | 691 | Q15811 | |
| GRGGEEKKKEKEKEE | 136 | P01880 | |
| EGEDEEGGERKKKKR | 946 | Q6PD62 | |
| EGGKRKADSDSEDKG | 81 | P83916 | |
| FKKNKKEAGEGGEAE | 171 | P29966 | |
| KKRKKGQEADLEAGG | 221 | Q9NX58 | |
| TAGEEEEKKKQKRGG | 86 | O43583 | |
| REKTGRKDKEDGEPK | 26 | Q8WUD4 | |
| GDFGGDEEKSRKRKN | 586 | Q14839 | |
| DGAQGKDKTKDKGRG | 391 | Q8N1G1 | |
| GNDSKKFKGEDKMDG | 41 | Q9UKA9 | |
| KEPDAVEKRGGKSDK | 141 | O95425 | |
| KGSDKRGDNQDKETG | 311 | Q86YW0 | |
| DKKKGKEEGQEDKGV | 381 | Q5QGS0 | |
| KEEGQEDKGVEKKDG | 386 | Q5QGS0 | |
| EDKGVEKKDGKDNGE | 391 | Q5QGS0 | |
| RKDDAKKGDDGSGEK | 521 | Q15424 | |
| KKGDDGSGEKSKDQD | 526 | Q15424 | |
| GDGERKTNDKDEKKE | 296 | Q9BXP5 | |
| QKKENSEGGEEEGKE | 701 | Q9NQW8 | |
| EDKGKENEDKDKGRE | 731 | Q9NQW8 | |
| EEEGDDQEGEKKRKG | 276 | O75475 | |
| KKKVKEDEDDGVGDG | 871 | Q5VZP5 | |
| EKNKNKEGDDKKEGG | 766 | Q96KR1 | |
| KEGDDKKEGGKDRAL | 771 | Q96KR1 | |
| GVDGFEAEGKKDKKD | 1056 | Q96KR1 | |
| GKDKVKGKRESEING | 526 | Q5SRN2 | |
| KGKRESEINGEKSKG | 531 | Q5SRN2 | |
| GEEKKADKKQREKGD | 146 | Q9UNY4 | |
| EKEKEKAGGEGGSEE | 771 | P07197 |